Photoactivated antibody conjugates
By forming covalent bonds between photoreactive probes in photoreactive kits and biomolecules, the problems of non-specific binding and slow reaction time in the study of biomolecule interactions in existing technologies are solved, and efficient and accurate biomolecule tagging and proximity labeling are achieved.
Patent Information
- Application Number
- CN202380032880.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-04-08
- Filing Date
- 2023-04-07
- Publication Date
- 2024-11-22
AI Technical Summary
Existing biomolecular interaction research techniques, such as yeast two-hybrid and proximity labeling techniques, suffer from problems such as non-specific binding, slow reaction time, and disruption of the natural cellular environment, leading to false positives and missed interactions.
The photoreactive kit, including the photoreactive probe GCB(I), is used to selectively label and mark biomolecules by forming covalent bonds between the photoreactive portion and the biomolecules through selective illumination of the microscope system.
It improves the accuracy and efficiency of identifying biomolecular interactions, reduces nonspecific binding and reaction time, and maintains the integrity of the natural cellular environment.
Smart Images

Figure CN119013558A_ABST
Abstract
Description
[0001] Priority claim
[0002] This application claims priority to U.S. Provisional Patent Application No. 63 / 329,219, filed on April 8, 2022, titled “PHOTOACTIVE ANTIBODY CONJUGATE,” which is incorporated herein by reference in its entirety.
[0003] Incorporated herein by reference
[0004] All publications and patent applications mentioned in this specification are herein incorporated by reference in their entirety to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference. Technical Field
[0005] The present invention describes methods and kits for identifying, labeling and analyzing biomolecules. The present invention specifically describes photoreactive kits that can be used for photoactivation and labeling of a subset of biomolecules. The methods and kits can be particularly useful for analyzing biological samples, such as identifying neighboring biomolecules in cell or tissue samples. Background Art
[0006] Cells are composed of different types of biomolecules. Biomolecules in cells interact with neighboring biomolecules in subcellular environments to form complexes, organelles or other combinations and to carry out various basic cellular functions. It is very challenging to characterize the subcellular environment in which biomolecules interact with each other and how biomolecules work together. Biomolecules are small and they exist in a cellular environment with tens of millions of other molecules. Interactions between neighboring biomolecules are usually weak and many techniques used to study biomolecules will destroy their interactions. Although techniques such as yeast two-hybridization assays and nearest neighbor labeling have helped to increase our understanding of the cellular environment, such techniques still suffer from various limitations, such as nonspecific binding, slow reaction times and disruption of the natural cellular environment, resulting in false positives and missed interactions. What is needed is better tools for determining naturally occurring biomolecular interactions to address these and other issues. Summary of the invention
[0007] The present invention describes methods and kits for identifying, labeling and analyzing biomolecules. The present invention specifically describes photoreactive kits that can be used for photoactivation and labeling of subsets of biomolecules. The methods and kits are particularly useful for analyzing biological samples, such as identifying neighboring biomolecules in cell or tissue samples. The kits are particularly useful for selectively labeling and neighboring marking biomolecules via selective light illumination through a microscope system.
[0008] The present invention describes a photoreactive kit comprising a photoreactive probe represented by formula (I): GCB (I), wherein the C portion is a single chemical bond or linker; the B portion comprises 1 to 50 photoreactive portions and is bound to the C portion, wherein each of the 1 to 50 photoreactive portions is derived from a ruthenium-based compound represented by formula (II):
[0009]
[0010] Wherein in formula (II): L 1 , L 2 , L 3 and L 4 Each is independently a ligand; and X 1 and X 2 Each is independently a ligand having a reactive portion, wherein the reactive portion is configured to bond to portion C; portion G includes a decoy molecule bound to portion C, wherein the decoy molecule is an antibody and is configured to conjugate to a first molecule in a sample. Such and other embodiments may include a primary target probe, which includes a detectable label portion bound to a photoexcitable target portion, wherein when the photoreactive probe is photoactivated with a two-photon light source in the wavelength range of 700 nm to 1100 nm or with a single light source in the wavelength range of 200 nm to 1100 nm and the primary target probe acts through the photoactivated probe to form a photoexcited primary target probe, the photoexcited primary target probe is configured to form a covalent bond with a target molecule in a sample.
[0011] In the above and other embodiments, the photoreactive kit may include X 1 and X 2 Each is independently selected from the group consisting of: 3-ethynylpyridine, 3-(bromomethyl)pyridine, maleimide, 4'-methyl-4-carboxybipyridyl-N-succinimide ester, nicotinaldehyde, 1-(4-(pyridin-3-yl)-1H-1,2,3-triazol-1-yl)ethanone, 4-pentynenitrile and 4-aminobutyne.
[0012] In the above and other embodiments, the photoreactive kit may include L 1 With L 2 to form a first bidentate ligand and L 3With L 4 The first bidentate ligand and the second bidentate ligand are independently selected from the group consisting of 2,2'-bipyridyl (bpy), 4,4'-dicyano-5,5'-dimethyl-2,2'-bipyridyl (CN-Me-bpy), 4,4'-dimethyl-2,2'-bipyridyl (dmb), 4,4'-di-tert-butyl-2,2'-bipyridyl (dbpy), 4,4',5,5'-tetramethyl-2,2'- Bipyridine (tmb), 2-phenylpyridine (ppy), 6-bromo-2,2'-bipyridine, 6,6'-dibromo-2,2'-bipyridine, 5-bromo-2,2'-bipyridine, 6-amino-2,2'-bipyridine, 6,6'-diamino-2,2'-bipyridine, 2,2'-bipyridine-6-carbonitrile, 2,2'-bipyridine-6,6'-bis(carbonitrile), 2,2'-bipyridine-6-carboxylic acid, 2,2'-bipyridine-6,6'-dicarboxylic acid and bisquinoline.
[0013] In these and other embodiments, the photoreactive kit may include a ruthenium-based compound of formula (II) that is one of the following:
[0014]
[0015]
[0016] and its derivatives.
[0017] In these and other embodiments, the photoreactive kit may include a portion wherein the photoreactive portion includes the following:
[0018]
[0019] or its derivatives.
[0020] In the above and other embodiments, the linker may include the following parts:
[0021]
[0022] In these and other embodiments, the photoreactive kit may include wherein the linker comprises amino acids, (PEG) n , oligonucleotide or peptide, wherein n is an integer from 1 to 20.
[0023] In such and other embodiments, the photoreactive kit may include wherein when the photoreactive probe is photoactivated with a two-photon light source in the wavelength range of 700 nm to 1100 nm and the primary target probe acts through the photoactivated probe to form a photoexcited primary target probe, the photoexcited primary target probe is configured to form a covalent bond with a target molecule in the sample. In such and other embodiments, the photoreactive kit may include further wherein when the photoreactive probe is photoactivated with a single light source in the wavelength range of 300 nm to 800 nm and the primary target probe acts through the photoactivated probe to form a photoexcited primary target probe, the photoexcited primary target probe is configured to form a covalent bond with a target molecule in the sample.
[0024] In the above and other embodiments, the photoreactive kit may include at least one of a biotin derivative, a digoxigenin tag, a CLIP-tag, a halogen tag, a SNAP-tag, an oligonucleotide, a peptide tag, and a click chemistry tag, and the click chemistry tag comprises an alkyne-based moiety or an azide-based moiety.
[0025] In these and other embodiments, the photoreactive kit may include a target moiety wherein the photoexcitable target moiety is at least one of:
[0026]
[0027] (R'=CH 2 CH 2 OMe or Et),
[0028] (X=N 2 + or Br), and its derivatives.
[0029] In these and other embodiments, the photoreactive kit can include those wherein the primary target probe is desthiobiotin-phenol or biotin-phenol.
[0030] In these and other embodiments, the photoreactive kit may include a photoexcitable target moiety
[0031] In these and other embodiments, the photoreactive kit may include a detectable tag portion that is at least one of a biotin derivative, a click chemistry tag, a CLIP-tag, a digoxigenin tag, a HaloTag, an oligonucleotide, a peptide tag, and a SNAP-tag, and the photoreactive portion includes a portion of the formula:
[0032]
[0033] In such and other embodiments, the photoreactive kit may include a linker, wherein the linker may be conjugated to a detectable label portion of a primary target probe. In such and other embodiments, the photoreactive kit may include wherein the linker is a fluorescent linker. In such and other embodiments, the photoreactive kit may include a tag-enzyme complex, wherein the tag-enzyme complex may be conjugated to the linker, and further wherein the enzyme of the tag-enzyme complex includes a peroxidase. In such and other embodiments, the photoreactive kit may include a linker, wherein the linker may be conjugated to a detectable label portion of a primary target probe; a tag-enzyme complex, wherein the tag of the tag-enzyme complex may be conjugated to the linker, and further wherein the enzyme of the tag-enzyme complex includes a peroxidase; and an additional target probe, which is configured to form a covalent bond with the target molecule by the catalytic activity of the peroxidase of the tag-enzyme complex to form an additional target probe. In such and other embodiments, the photoreactive kit may include wherein the additional target probe is the same as or different from the primary target probe and includes an additional target probe tag portion and an additional target probe target portion. In such and other embodiments, the photoreactive kit may include wherein the linker is a fluorescent linker.
[0034] In these and other embodiments, the photoreactive kit can include a photoreactive probe having a concentration ranging from 0.1 μg / mL to 100 μg / mL and a primary target probe having a concentration ranging from 1 μM to 20 mM.
[0035] The present invention also describes a photoreactive kit comprising a photoreactive probe represented by formula (I): GCB (I), wherein portion C is a single chemical bond or linker; portion B comprises at least one photoreactive moiety bound to portion C; and portion G comprises a decoy molecule bound to portion C. In these and other embodiments, the photoreactive kit may include a primary target probe comprising a detectable label moiety bound to a photoexcitable target moiety, wherein the decoy molecule of the photoreactive probe is configured to be conjugated to a first molecule in a sample, and wherein when the photoreactive probe is photoactivated and the primary target probe acts through the photoactivated probe to form a photoexcited primary target probe, the photoexcited primary target probe is configured to form a covalent bond with the target molecule in the sample.
[0036] In these and other embodiments, the photoreactive kit may include a bait molecule that includes at least one of the following: an antibody, avidin, neutravidin, streptavidin, another biotin-binding protein, a CLIP-tag, a halogen tag, a SNAP-tag, another self-labeled protein tag, a DNA or RNA fluorescent in situ hybridization (FISH) probe, another RNA molecule, another nucleic acid molecule, protein A, protein G, protein L, protein A / G, protein A / G / L, another immunoglobulin binding peptide, a drug, or another small molecule.
[0037] In these and other embodiments, the photoreactive kit can include a photoreactive moiety that is at least one of riboflavin, luciferin, another flavin derivative, luciferin or a derivative thereof, methylene blue or a derivative thereof, miniSOG photosensitive protein, Killer Red photosensitive protein, another photosensitive protein, pterin or a derivative thereof, a ruthenium-based photocatalyst, and Rose Bengal or a derivative thereof.
[0038] In these and other embodiments, the photoreactive kit can include wherein the decoy molecule is an antibody and a certain number of photoreactive moieties are conjugated to the antibody via moieties C, wherein the certain number ranges from 1 to 50.
[0039] In these and other embodiments, the photoreactive kit can include a photoreactive portion configured to allow the primary target probe to form a covalent bond with a molecule of the sample.
[0040] In these and other embodiments, the photoreactive kit may include wherein the photoreactive moiety is derived from a ruthenium-based compound represented by formula (II):
[0041]
[0042] Wherein in formula (II): L 1 , L 2 , L 3 and L 4 Each is independently a ligand; and
[0043] X 1 and X 2 Each is independently a ligand, wherein X 1 and X 2 At least one of the photoreactive probes has a binding region, wherein at least one binding region binds to the C portion of the photoreactive probe.
[0044] In the above and other embodiments, the photoreactive kit may include X 1 and X 2Each is independently selected from the group consisting of: 3-ethynylpyridine, 3-(bromomethyl)pyridine, maleimide, 4'-methyl-4-carboxybipyridyl-N-succinimide ester, nicotinaldehyde, 1-(4-(pyridin-3-yl)-1H-1,2,3-triazol-1-yl)ethanone, 4-pentynenitrile and 4-aminobutyne.
[0045] In the above and other embodiments, the photoreactive kit may include L 1 With L 2 to form a first bidentate ligand and L 3 With L 4 The first bidentate ligand and the second bidentate ligand are independently selected from the group consisting of 2,2'-bipyridyl (bpy), 4,4'-dicyano-5,5'-dimethyl-2,2'-bipyridyl (CN-Me-bpy), 4,4'-dimethyl-2,2'-bipyridyl (dmb), 4,4'-di-tert-butyl-2,2'-bipyridyl (dbpy), 4,4',5,5'-tetramethyl-2,2'- Bipyridine (tmb), 2-phenylpyridine (ppy), 6-bromo-2,2'-bipyridine, 6,6'-dibromo-2,2'-bipyridine, 5-bromo-2,2'-bipyridine, 6-amino-2,2'-bipyridine, 6,6'-diamino-2,2'-bipyridine, 2,2'-bipyridine-6-carbonitrile, 2,2'-bipyridine-6,6'-bis(carbonitrile), 2,2'-bipyridine-6-carboxylic acid, 2,2'-bipyridine-6,6'-dicarboxylic acid and bisquinoline.
[0046] In these and other embodiments, the photoreactive kit may include a ruthenium-based compound of formula (II) that is any of the following:
[0047]
[0048]
[0049] and its derivatives.
[0050] In these and other embodiments, the photoreactive kit may include a portion wherein the photoreactive portion includes the following:
[0051]
[0052] or its derivatives.
[0053] In these and other embodiments, the photoreactive kit may include a linker comprising the following:
[0054] In these and other embodiments, the photoreactive kit may include wherein the linker comprises amino acids, (PEG) n , oligonucleotide or peptide, wherein n is an integer from 1 to 20.
[0055] In these and other embodiments, the photoreactive kit can include a photoreactive moiety that is activatable with a light source in the wavelength range of 200 nm to 1100 nm to allow the primary target probe to form a covalent bond with a target molecule in a sample.
[0056] In such and other embodiments, the photoreactive kit may include wherein the photoreactive moiety is activatable with a two-photon light source in the wavelength range of 700 nm to 1100 nm to allow the primary target probe to form a covalent bond with a target molecule in a sample. In such and other embodiments, the photoreactive kit may include wherein the photoreactive moiety is activatable with a light source in the wavelength range of 300 nm to 800 nm to allow the primary target probe to form a covalent bond with a target molecule in a sample.
[0057] In these and other embodiments, the photoreactive kit can include a photoreactive moiety that is activatable with a two-photon light source in the wavelength range of 700 nm to 1100 nm to allow the primary target probe to form a covalent bond with a target molecule in a sample.
[0058] In the above and other embodiments, the photoreactive kit may include at least one of a biotin derivative, a CLIP-tag, a digoxigenin tag, a halogen tag, an oligonucleotide, a peptide tag, a SNAP-tag, and a click chemistry tag, and the click chemistry tag comprises an alkyne-based moiety or an azide-based moiety.
[0059] In these and other embodiments, the photoreactive kit may include wherein the target moiety is one or more of the following:
[0060] (R'=CH 2 CH 2 OMe or Et), (X=N 2 + or Br), and its derivatives.
[0061] In these and other embodiments, the photoreactive kit can include those wherein the primary target probe is desthiobiotin-phenol or biotin-phenol.
[0062] In these and other embodiments, the photoreactive kit may include a photoexcitable target moiety
[0063] In these and other embodiments, the photoreactive kit may include wherein the detectable tag moiety is at least one of a biotin derivative, a click chemistry tag, a CLIP-tag, a digoxigenin tag, a halogen tag, an oligonucleotide, a peptide tag, and a SNAP-tag, and the photoreactive moiety includes a moiety of the formula:
[0064] In such and other embodiments, the photoreactive kit may include a linker, wherein the linker may be conjugated to a detectable label portion of the primary target probe. In such and other embodiments, the photoreactive kit may include wherein the linker is a fluorescent linker. In such and other embodiments, the photoreactive kit may include a tag-enzyme complex, wherein the tag-enzyme complex may be conjugated to the linker, and further wherein the enzyme of the tag-enzyme complex includes a peroxidase.
[0065] In the above and other embodiments, the photoreactive kit may include a linker, wherein the linker can be conjugated to a detectable label portion of a primary target probe; a label-enzyme complex, wherein the label of the label-enzyme complex can be conjugated to the linker, and further wherein the enzyme of the label-enzyme complex includes a peroxidase; and an additional target probe, which is configured to form a covalent bond with the target molecule through the catalytic activity of the peroxidase of the label-enzyme complex to form the additional target probe.
[0066] In such and other embodiments, the photoreactive kit may include wherein the additional target probe is different from the primary target probe and includes an additional target probe tag portion and an additional target probe target portion. In such and other embodiments, the photoreactive kit may include wherein the linker is a fluorescent linker.
[0067] In these and other embodiments, the photoreactive kit can include a photoreactive probe having a concentration ranging from 0.1 μg / mL to 100 μg / mL and a primary target probe having a concentration ranging from 1 μM to 20 mM.
[0068] The present invention also describes methods for photoreactive labeling. Such and other methods may include one or more of the following steps: delivering a number of photoreactive probes of a photoreactive set to a sample; non-covalently conjugating a decoy molecule of a first portion of the photoreactive probe to a number of first molecules in the sample; delivering a number of primary target probes of a photoreactive set as described herein to a sample; selectively illuminating a selected region of interest of the sample with optical radiation to activate the photoreactive portions of the number of photoreactive probes to form a number of photoactivated photoreactive probes in the selected region; photoexciting the photoexcitable target portions of the primary target probes by the number of photoactivated photoreactive probes to form a number of photoexcited primary target probes having photoexcited target portions; and forming covalent bonds between the number of photoexcited primary target probes and a number of target molecules in the selected region of interest in the sample to bind the number of primary target probes to the number of target molecules.
[0069] In the above and other methods in which the bait molecules of the first portion of the photoreactive probe are non-covalently conjugated with a certain number of first molecules in the sample to leave the second portion of the photoreactive probe unconjugated, the method may further include the following step: removing the unconjugated photoreactive probe from the sample.
[0070] These and other methods may further comprise one or more of the following steps: delivering a number of linkers to a sample; and conjugating a number of linkers to a detectable label moiety of a number of primary target probes.
[0071] In such and other methods in which a certain number of linkers include fluorescent linkers, the method may further include one or more of the following steps: detecting the positions of a certain number of fluorescent linkers in a sample, and thereby identifying the positions of a certain number of primary target probes and a certain number of target molecules covalently bound thereto.
[0072] In the above and other methods, the step of photoexcitation may further include the following steps:
[0073] The primary target probe is photoexcited to form a certain number of photoexcited primary target probes each having a free radical, and the step of forming a covalent bond includes forming a covalent bond between each of the certain number of photoexcited primary target probes and an amino acid in each of a certain number of target molecules in a selected region of interest in the sample.
[0074] In such and other methods, the step of forming a covalent bond may include forming a covalent bond between each of a number of photoexcited primary target probes and an amino acid in each of a number of target molecules in a selected region of interest in the sample.
[0075] In these and other methods, the amino acid can be selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine.
[0076] Such and other methods may further include one or more of the following steps: delivering a linker of a photoreactive kit as described herein to a sample, wherein the linker can be conjugated to a detectable label portion of a primary target probe; delivering a tag-peroxidase complex of a photoreactive kit as described herein to a sample, wherein the tag of the tag-enzyme complex can be conjugated to the linker, and further wherein the enzyme of the tag-enzyme complex comprises a peroxidase; delivering an additional target probe of a photoreactive kit as described herein to a sample, wherein the additional target probe is configured to form a covalent bond with a target molecule through the catalytic activity of the peroxidase of the tag-enzyme complex to form a covalent bond between the additional target probe and the sample; and conjugating the tag-peroxidase complex to the linker, wherein the tag-peroxidase catalyzes the additional target probe to form a covalent bond between the additional target probe and the sample.
[0077] In such and other methods, the tag-peroxidase complex can activate the attached target probe to have a free radical at the target portion of the attached target probe and form a covalent bond between the target portion of the attached target probe and tyrosine of the sample.
[0078] The present invention also describes an analytical method, which includes one or more of the following steps: delivering a certain number of photoreactive probes of the photoreactive kit as described herein to a sample; non-covalently conjugating the bait molecule of the first part of the photoreactive probe to a certain number of first molecules in the sample; delivering a certain number of primary target probes of the photoreactive kit as described herein to the sample; and illuminating the sample with an imaging light source from an image guidance system; imaging the illuminated sample with a camera; acquiring at least one subcellular morphology image of the sample in a first field of view with the camera; processing at least one image and determining a region of interest in the sample based on the processed image; obtaining coordinate information of the region of interest; and selectively illuminating the region of interest by light radiation based on the coordinate information to activate the photoreactive portion, wherein the activated photoreactive portion allows the primary target probe to form a covalent bond with the sample at the region of interest.
[0079] These and other methods may include illuminating an area at 10 μs / pixel to 200 μs / pixel, 25 μs / pixel to 400 μs / pixel, 50 μs / pixel to 300 μs / pixel, 75 μs / pixel to 200 μs / pixel, or 400 μs / pixel to 5000 μs / pixel.
[0080] In the above and other methods, the step of selectively illuminating includes illuminating at a power intensity of 1 μW to 300 mW. In the above and other methods, the step of selectively illuminating includes illuminating a segment defined by a point spread function.
[0081] These and other methods may further comprise the steps of conjugating a linker to a primary target probe and detectably proximity-labeling a neighboring molecule in proximity to the target molecule via a detectable labeling activity.
[0082] In such and other methods, the step of detectably proximate to a label may include proximate to an area of the label having a diameter of less than 5 μm, less than 2 μm, less than 1 μm, less than 500 nm, less than 300 nm, less than 200 nm, less than 100 nm, less than 50 nm, or less than 20 nm.
[0083] In these and other methods, the linker can include a catalytic tag.
[0084] In the above and other methods, the sample can include at least 1, at least 100, at least 1000 or at least 10,000 living or fixed cells. In the above and other methods, the sample can include fixed cells, fixed tissues, cell extracts or tissue extracts.
[0085] These and other methods may include the step of subjecting the selectively illuminated sample to mass spectrometry or sequencing analysis.
[0086] In these and other methods, the activated photoactivatable moiety can activate the primary target probe to have a free radical and form a covalent bond with an amino acid of the sample at a selected region of interest.
[0087] The present invention also describes a mass spectrometry implementation method for processing samples to predict biomarkers. The present invention describes a method that may include one or more of the following steps: dividing a sample into a photo-labeled sample group and an unlabeled sample group; delivering a light-reactive probe and a primary target probe as described herein to the photo-labeled sample group and the unlabeled sample group; selectively illuminating a selected area of interest of the photo-labeled sample group and keeping the unlabeled sample group in the dark, wherein the illuminating step allows the primary target probe to form a covalent bond with the sample; extracting a certain number of probe-bound proteins from the photo-labeled sample group and the unlabeled sample group by affinity precipitation between the primary target probe and a certain number of affinity magnetic beads; subjecting the extracted proteins to mass spectrometry analysis; calculating the relative quantitative value of individual proteins in the identified protein list between the photo-labeled sample group and the unlabeled sample group based on the intensity value of the peptide fragment of the individual proteins; determining a threshold value of the relative quantitative value between the photo-labeled sample group and the unlabeled sample group; and after determining the threshold value, predicting at least one biomarker corresponding to the relative quantitative value of the individual proteins exceeding the threshold value.
[0088] These and other methods may further comprise the step of non-covalently conjugating the bait molecule to the target molecule in the sample.
[0089] In such and other methods, the step of selectively illuminating the selected region of interest may further include the step of activating the photoreactive moiety in the selected region, thereby allowing the activated photoreactive moiety to allow the primary target probe to form a covalent bond with the sample in the selected region of interest.
[0090] These and other methods may further comprise the step of delivering a decoy molecule of the photoreactive probe to the sample.
[0091] These and other methods may further include the step of removing the unconjugated photoreactive probe from the sample, thereby allowing the photoreactive probe to direct selective illumination at selected regions of interest.
[0092] These and other methods may further comprise the steps of delivering a linker of a photoreactive kit as described herein to a sample and conjugating the linker to the primary target probe via affinity between the linker and the primary target probe.
[0093] In these and other methods, the linker is a fluorescent linker that is used to identify the location of the sample to which the primary target probe is covalently bound.
[0094] In these and other methods, the activated photoreactive moiety can activate the primary target probe to have a free radical and form a covalent bond with an amino acid of the sample at a selected region of interest.
[0095] In these and other methods, the amino acid can be selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine.
[0096] These and other methods may further include the steps of delivering a tag-peroxidase of a photoreactive kit as described herein to a sample and conjugating the tag-peroxidase to a linker, thereby allowing the tag-peroxidase to catalyze the attached target probe to form a covalent bond between the attached target probe and the sample.
[0097] In such and other methods, the tag-peroxidase can activate the attached target probe to have a free radical at the target portion of the attached target probe and form a covalent bond between the target portion of the attached target probe and the tyrosine of the sample.
[0098] The present invention also describes a mass spectrometry-implemented method for processing a photolabeled sample to identify a list of biomarkers. The present invention describes a method comprising one or more of the following steps: obtaining a sample; delivering a photoreactive kit as described herein to the sample; selectively illuminating a selected region of interest of the biological sample, thereby allowing a primary target probe to label proteins of the sample at the selected region of interest; extracting a certain number of probe-labeled proteins from the sample by affinity precipitation between the primary target probe and a certain number of affinity magnetic beads; subjecting the extracted proteins to mass spectrometry analysis; and identifying the extracted proteins of the sample.
[0099] Such and other methods may further comprise the step of calculating intensity values for peptide fragments of each protein of the list of identified proteins of the sample.
[0100] These and other methods may further include the step of sorting the list of identified proteins according to the intensity value of each protein.
[0101] These and other methods may further comprise the step of non-covalently conjugating the bait molecule to the target molecule in the sample.
[0102] In such and other methods, the step of selectively illuminating the selected region of interest may further include the step of activating the photoreactive moiety in the selected region, thereby allowing the activated photoreactive moiety to allow the primary target probe to form a covalent bond with the sample in the selected region of interest.
[0103] These and other methods may further comprise the step of delivering a decoy molecule of the photoreactive probe to the sample.
[0104] These and other methods may further include the step of removing unconjugated photoreactive probes from the sample, thereby allowing the photoreactive probes to direct selective illumination at selected regions of interest.
[0105] These and other methods may further comprise the steps of delivering a linker of a photoreactive kit as described herein to a sample and conjugating the linker to the primary target probe via affinity between the linker and the primary target probe.
[0106] In these and other methods, the linker can be a fluorescent linker configured to identify the location of a sample to which a primary target probe is covalently bound.
[0107] In these and other methods, the activated photoreactive moiety can activate the primary target probe to have a free radical and form a covalent bond with an amino acid of the sample at a selected region of interest. In these and other methods, the amino acid can be selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine.
[0108] These and other methods may further include the steps of delivering a tag-peroxidase of a photoreactive kit as described herein to a sample and conjugating the tag-peroxidase to a linker, thereby allowing the tag-peroxidase to catalyze the attached target probe to form a covalent bond between the attached target probe and the sample.
[0109] In such and other methods, the tag-peroxidase can activate the attached target probe to have a free radical at the target portion of the attached target probe and form a covalent bond between the target portion of the attached target probe and the tyrosine of the sample. BRIEF DESCRIPTION OF THE DRAWINGS
[0110] A better understanding of the features and advantages of the methods and devices described herein will be obtained by referring to the following detailed description and accompanying drawings which set forth illustrative embodiments, in which:
[0111] [ Figure 1 ] shows a schematic diagram of a system that can be used to photoselectively spatially tag and proximity-label cells on a substrate.
[0112] [ Figure 2A ] shows a schematic illustration of a photoreactive probe having a label portion and a target portion.
[0113] [ Figure 2B ] shows a schematic illustration of a target probe having a label portion and a target portion.
[0114] [ Figure 2C] shows an example of a target probe having a desthiobiotin tag moiety and a phenol target moiety.
[0115] [ Figure 2D ] The diagram illustrates a target probe having a label portion and a reactive phenol portion.
[0116] [ Figure 2E ] To illustrate the interaction of the photoreactive probe with the target probe, use Figure 2D The target probes shown enable labeling of adjacent proteins.
[0117] [ Figures 2F to 2G ]Used by illustration Figure 2A and 2B The probes shown are adjacent to the steps for labeling biomolecules in the target region. Figure 2F The diagram illustrates the binding of a photoreactive probe to a first molecule.
[0118] [ Figure 2G ] The illustrations are as follows Figure 2F The photoreactive probe shown binds to a first molecule, undergoes light-driven activation of the photoreactive probe, and binds to an adjacent biomolecule.
[0119] [ Figure 2H ] The illustrations can be used to illustrate the Figure 2A and 2B The probes shown are labeled with a proximity labeling system for biomolecules.
[0120] [ Fig.2I ] shows schematic illustrations comparing different methods for labeling biomolecules in a small region of interest (ROI). The upper right panel illustrates direct photochemical labeling and the lower panel illustrates light-assisted enzymatic labeling of a protein of interest using a photoreactive probe and a target probe as described herein.
[0121] [ Figures 3A to 3N ] shows examples of ruthenium-based photoreactive moieties that can be used in the photoreactive probes described herein. Figure 3A Shown are examples of ruthenium-based photoreactive moieties that can be used in the photoreactive probes and methods described herein.
[0122] [ Figure 3B ] shows another example of a ruthenium-based photoreactive moiety.
[0123] [ Figure 3C ] shows another example of a ruthenium-based photoreactive moiety.
[0124] [ Figure 3D ] shows another example of a ruthenium-based photoreactive moiety.
[0125] [ Figure 3E ] shows another example of a ruthenium-based photoreactive moiety.
[0126] [ Figure 3F ] shows another example of a ruthenium-based photoreactive moiety.
[0127] [ Figure 3G ] shows another example of a ruthenium-based photoreactive moiety.
[0128] [ Figure 3H ] shows another example of a ruthenium-based photoreactive moiety.
[0129] [ Fig. 3I ] shows another example of a ruthenium-based photoreactive moiety.
[0130] [ Figure 3J ] shows another example of a ruthenium-based photoreactive moiety.
[0131] [ Figure 3K ] shows another example of a ruthenium-based photoreactive moiety.
[0132] [ Figure 3L ] shows another example of a ruthenium-based photoreactive moiety.
[0133] [ Figure 3M ] shows another example of a ruthenium-based photoreactive moiety.
[0134] [ Figure 3N ] shows another example of a ruthenium-based photoreactive moiety.
[0135] [ Fig.3O ] shows examples of Rose Bengal moieties and derivatives thereof that can be used in the photoreactive probes and methods described herein.
[0136] [ Figures 3P to 3Q ] shows examples of luciferin derivatives that can be used in the photoreactive probes and methods described herein.
[0137] [ Figure 3R ] shows examples of methylene blue derivatives that can be used in the photoreactive probes and methods described herein.
[0138] [ Figures 3S to 3T ] shows examples of photoflavin derivatives that can be used in the photoreactive probes and methods described herein.
[0139] [ Figure 3U to 3V ] shows examples of riboflavin and flavin derivatives that can be used in the photoreactive probes and methods described herein.
[0140] [ Figure 3W and 3X ] shows examples of pterin derivatives that can be used in the photoreactive probes and methods described herein.
[0141] [ Figure 3Y] shows another example of a ruthenium-based photoreactive moiety.
[0142] [ Figure 3Z ] shows another example of a ruthenium-based photoreactive moiety.
[0143] [ Figure 3AA ] shows another example of a ruthenium-based photoreactive moiety.
[0144] [ Figure 3AB ] shows another example of a ruthenium-based photoreactive moiety.
[0145] [ Figure 3AC ] shows another example of a ruthenium-based photoreactive moiety.
[0146] [ Figure 3AD ] shows another example of a ruthenium-based photoreactive moiety.
[0147] [ Figure 3AE ] shows another example of a ruthenium-based photoreactive moiety.
[0148] [ Figure 3AF ] shows another example of a ruthenium-based photoreactive moiety.
[0149] [ Figure 3AG ] shows another example of a ruthenium-based photoreactive moiety.
[0150] [ Figure 3AH ] shows another example of a ruthenium-based photoreactive moiety.
[0151] [ Figure 3AI ] shows another example of a ruthenium-based photoreactive moiety.
[0152] [ Figures 4A to 4L ] shows examples of linker moieties that can be used in the photoreactive probes described herein.
[0153] [ Figures 5A to 5E ] shows examples of labels that can be used for the target probes described herein. Figures 5A to 5E Display of click chemistry molecules.
[0154] [ Figures 5F to 5H ] shows biotin derivatives that can be used in the probes and methods described herein.
[0155] [ Fig.5I ] shows digoxigenin that can be used in the probes and methods described herein.
[0156] [ Figure 5J ] shows examples of peptide tags that can be used in the probes and methods described herein.
[0157] [ Figure 5K ] shows examples of SNAP-tags that can be used in the probes and methods described herein.
[0158] [ Figures 6A to 6L ] shows examples of target moieties that can be used in the target probes described herein.
[0159] [ Figure 7 ]Ru(bpy) 3 2+ Conjugation to antibodies was performed via NHS ester-based amide coupling to form photoreactive probes.
[0160] [ Figure 8 ] shows the experimental results of antibody-based ruthenium (Ab-Ru) targeted photolabeling (confocal imaging of nucleolar markers (magenta; first image of XY and Z axis results), antibody-based ruthenium (red; second image from the left of the XY axis and second image from the bottom of the Z axis), photo(2P) labeled signal: desthiobiotin (green; third image from the left of the XY axis and third image from the bottom of the Z axis); scale bar: 20 μm).
[0161] [ Fig. 9 ] shows that a small region of interest (nucleolus) is accurately photolabeled using the Ab-Ru photoreactive probe and biotin-phenol target probe and methods disclosed herein. Fig. 9 Shown are results from nucleolar labeling experiments ( Figure 8 ), wherein the proteins are ranked by their logarithmic fold change ratio of labeled cells to unlabeled cells.
[0162] [ Fig.10 ] shows previously unidentified proteins in stress granules (SGs) identified using the probes and methods disclosed herein. Proteomic composition reveals the accuracy and power of discovering novel proteins using such methods.
[0163] [ Figures 11A to 11D ] shows strong light labeling using photoreactive moieties. Figures 11A to 11C Chemical structures showing parts of ruthenium, riboflavin, and rose bengal. Fig.11D Display usage Figures 11A to 11C Fluorescent labeling of the photoreactive fraction of cells is shown.
[0164] [ Fig.12 ] showed that the photoreactive moiety was successfully conjugated to the antibody.
[0165] [ Figures 13A to 13B ] shows the result of successful conjugation of the photoreactive moiety to the antibody.
[0166] [ Figures 14A to 14C ] show the results of specific photolabeling of induced cells using ruthenium-based photoreactive moieties conjugated to antibodies. Fig.14A Shown is illumination at 470 nm. Fig. 14B A control group (no light) is shown. Fig. 14C Show in Fig.14A The cells are shown in the Z-axis (side view).
[0167] [ Fig.15 ] shows selective photolabeling of mouse brain tissue samples using a probe with a ruthenium-based photoreactive moiety and an antibody. The control group (no light) shows no labeling.
[0168] [ Fig.16 ] show experimental results showing photolabeling of mouse brain tissue samples using ruthenium-based photoreactive moieties and probes with antibodies and neutravidin staining.
[0169] [ Fig.17 ] shows experimental results showing detection of nucleolar regions using a probe with a ruthenium-based photoreactive moiety and a secondary antibody bait. The photolabeled signal was labeled using two-photon technology.
[0170] [ Figures 18A to 18C ] show experimental results showing detection of photolabeled subcellular compartments using probes with ruthenium-based photoreactive moieties and Alexa fluor 568 secondary antibody baits bound to primary antibodies. Fig.18A Nucleolar detection using rabbit anti-nucleolin antibody is shown. Fig.18B Results of an experiment showing nuclear pore complex detection using mouse anti-NPC antibody are shown. Fig.18C Stress granule detection using mouse anti-Ras GTPase-activating protein-binding protein 1 antibody is shown.
[0171] [ Fig.19 ] show experimental results showing specific two-photon labeling in fixed mouse brain tissue.
[0172] [ Fig. 20 ] show experimental results showing that photolabeled stress granules were covalently bound to tyrosine residues at and adjacent to the enzyme site using horseradish peroxidase-activated desthiobiotin.
[0173] [ Fig.21 ] shows proximity labeling of a photolabeled mouse liver tissue sample using horseradish peroxidase-activated desthiobiotin covalently attached to tyrosine residues at and adjacent to the enzyme site.
[0174] [ Fig. 22 ] shows an example of a workflow using a photoactivation kit in conjunction with a microscope photolabeling system, followed by mass spectrometry analysis as described herein.
[0175] [ Fig.23] show experimental results showing confocal micrographs depicting precise and accurate photolabeling (PL) of stress granules with an antibody-ruthenium photoactivatable probe using a two-photon labeling system at wavelength = 780 nm.
[0176] [ Figures 24A to 24C ] shows two-photon labeling using an antibody-ruthenium photoactivatable probe. Fig.24A Fann diagram showing three biological replicates of two-photon labeling of the Ab-Ru photoactivatable probe. Fig. 24B Volcano plot showing relative protein levels (ratio of PL / CTL) in photolabeled samples versus control samples in the log2 dimension. Overrepresented (enriched) proteins are shown in the upper right bounded by arrows a and b. Fig.24C It was shown that a 74% true positive rate (annotated as stress granules (sg)) was found among the top 50 proteins ranked by the PL / CTL ratio.
[0177] [ Figures 25A to 25B ] shows an example of the results of validating potential stress granule proteins by immunofluorescence detection. Fig.25A It was shown that 37 of the top 50 proteins ranked by PL / CTL ratio were annotated as stress granule proteins. Fig.25B Proteomic compositions are shown that confirm the accuracy of detecting stress granule proteins using the methods herein and the ability to discover novel stress granule biomarkers using such methods. DETAILED DESCRIPTION
[0178] The present invention describes systems, kits and methods for identifying, labeling, obtaining and analyzing biomolecules and their neighboring biomolecules. Kits and methods can be particularly useful for analyzing biomolecular interactions in biological samples, such as analyzing proteins, nucleic acids, carbohydrates or lipids in cell or tissue samples. Kits and methods can be advantageously used to identify and / or isolate previously unknown biomarkers (e.g., neighboring or adjacent molecules), such as using protein sequencing and / or mass spectrometry. Kits and methods utilize photoreactive materials that can label biomolecules and their neighboring biomolecules. The photoreactive kits described herein can be particularly useful for specifically labeling subsets of biomolecules in subcellular regions of cells, using an image-guided microscope with precise illumination control, such as the system described in U.S. Patent Publication No. 2018 / 0367717, so as to enable automatic labeling of cellular biomolecules of interest. Kits can be used for in situ labeling of biomolecules (such as proteins inside cells or tissues), and can then be adjacently labeled, such as using Tyramide Signal Amplification (TSA). The biomolecules can be further analyzed by analytical techniques, such as mass spectrometry and sequencing. Such kits are particularly useful for performing omics studies, such as genomics, proteomics, and transcriptomics, and for finding relevant biomarkers for diagnosis and treatment.
[0179] Abbreviations and definitions:
[0180] The term "amino acid" refers to naturally occurring and synthetic amino acids, as well as amino acid analogs and amino acid mimetics that function in a manner similar to the naturally occurring amino acids. Naturally occurring amino acids are those encoded by the genetic code, as well as amino acids that are subsequently modified, such as hydroxyproline, γ-carboxyglutamate, and O-phosphoserine. "Amino acid analogs" refer to compounds that have the same basic chemical structure as naturally occurring amino acids, i.e., an alpha carbon bonded to a hydrogen, a carboxyl group, an amino group, and an R group, such as homoserine, norleucine, methionine sulfoxide, methionine methyl sulfonium. The amino acids described herein may be conservatively substituted as long as the conservatively substituted peptide has the desired function (such as being recognized by a protease). Examples of conservative substitutions include Thr, Gly, or Asn for Ser, and His, Lys, Glu, or Gln for Arg. Conservative substitutions are described, for example, in Molecular Cloning: A Laboratory Manual, Fourth Edition, Green and Sambrook, eds., Cold Spring Harbor Laboratory Press, Cold Spring Harbor 2014, and revised and updated editions thereof.
[0181] The term "antibody" refers to immunoglobulins and related molecules, and includes monoclonal antibodies, polyclonal antibodies, monomers, dimers, multimers, multispecific antibodies (e.g., bispecific antibodies), heavy chain antibodies only, triabodies, single-chain Fvs, and nanobodies. Antibodies may be polyclonal or monoclonal or recombinant antibodies. Antibodies may be murine, human, donkey, goat, humanized, chimeric, or derived from other species. As used herein, when an antibody or other entity "specifically recognizes" or "specifically binds" an antigen or epitope, it preferentially recognizes an antigen in a complex mixture of proteins and / or macromolecules and binds to the antigen or epitope with substantially higher affinity than other entities that do not display the antigen or epitope. Primary antibodies bind to specific antigens. Secondary (tertiary, etc.) antibodies often specifically bind to another antibody and usually to an antibody class or subclass through the Fc domain on other antibodies.
[0182] The term "antigen-binding fragment" refers to an antibody fragment that binds to an antigen or epitope.
[0183] The term "bait molecule" refers to a molecule that specifically interacts with a molecule of interest, which may be referred to as a target (or prey). Examples of bait molecules include antibodies, CLIP-tags, drugs, nucleic acids, fluorescent in situ hybridization (FISH) probes, protein A, protein G, protein L, protein A / G, protein A / G / L, another small molecule, and SNAP-tags.
[0184] The term "binding" refers to the physical interaction of a first part and a second part, wherein the first part and the second part are in physical contact with each other.
[0185] The term "biotin derivative" refers to a biotin moiety, including biotin and variants of biotin, such as biotin with an open ring or substitutions. Biotin derivatives are generally easily detectable with a biotin binding entity or protein, such as avidin, neutravidin or streptavidin.
[0186] The term "biotin binding protein" refers to a protein that specifically binds biotin with high affinity. Examples of biotin detection reagents are avidin, neutravidin or streptavidin, each of which can bind to four structural analogs of biotin.
[0187] The term "catalyzed reporter deposition" (CARD) refers to the enzymatic deposition of a detectable molecule on or near a target biomolecule (e.g., a carbohydrate, lipid, nucleic acid, or protein). In some embodiments, the enzyme in the enzymatic deposition is horseradish peroxidase (HRP) and the detectable molecule is tyramide or digoxygenin (DIG).
[0188] The term "click chemistry" refers to a chemical method that easily joins molecular building blocks. Click chemistry reactions are generally efficient, high-yield, reliable, produce few or no by-products, and are compatible with aqueous environments or do not require the addition of solvents. Examples of click chemistry are cycloaddition reactions (such as the copper (I)-catalyzed [3+2]-Huisgen 1,3-dipolar cycloaddition reaction of alkynes and azides leading to 1,2,3-triazole formation) or Diels-Alder reactions. Click chemistry also includes copper-free reactions, such as variations using substituted cyclooctynes (see, e.g., JM Baskin et al., Proc. Natl. Acad. Sci. USA 2007 Oct. 23, 104 (43), 16793-16797.). Other examples of click chemistry are nucleophilic substitution; addition reactions of CC multiple bonds (e.g., Michael addition, epoxidation, dihydroxylation, aziridination); and nonaldol like chemistry (e.g., N-hydroxysuccinimide active ester coupling). Click chemistry reactions can be bioorthogonal, but are not required.
[0189] The term "conjugation" refers to a process by which two or more molecules are allowed to interact specifically with each other. In some embodiments, a tag is conjugated to a label. In some embodiments, a bait is conjugated to a biomolecule.
[0190] The term "conjugable" refers to a molecule that can be specifically conjugated to another molecule. In some embodiments, the decoy can be conjugated to a biomolecule of interest. In some embodiments, the linker can be conjugated to a primary target probe.
[0191] The term "detectable label" refers to a compound or composition that is intended or configured to be conjugated directly or indirectly to a molecule. The label itself can be detectable and be a directly detectable label (such as a fluorescent label, such as a fluorescent chemical adduct, a radioisotope label, etc.), or the label can be indirectly detectable (such as in the case of an enzyme-detectable label, the enzyme can catalyze a chemical change in the substrate compound or composition and the reaction product is detectable). Examples of detectable labels include, for example, a biotin label, a fluorescent label, horseradish peroxidase, an immunologically detectable label (e.g., a hemagglutinin (HA) tag, a polyhistidine tag), another luminescent label, and a radioactive label. An example of an indirect label is biotin, which can be detected using a streptavidin detection method.
[0192] The term "immunoglobulin binding peptide" refers to a peptide that can specifically bind to a region other than the complementary determining region (CDR) / fragment antigen binding (Fab) region of an immunoglobulin molecule (antibody) with high affinity. An immunoglobulin binding peptide is not an antibody that binds to other antibodies (e.g., not a secondary antibody). An immunoglobulin binding peptide is typically bound to the Fc (fragment, crystallizable) region of an immunoglobulin (antibody). An immunoglobulin binding peptide is typically an immunoglobulin binding protein, a mimetic thereof, and a variant thereof, including a recombinant variant, of an immunoglobulin-binding bacterial protein. Examples of non-antibody immunoglobulin binding proteins include protein A, protein G, protein L, protein Z, protein A / G, and protein A / G / L. Protein A and protein G are bacterial proteins originally obtained from Staphylococcus aureus and group G streptococci, respectively, and have a high affinity for the Fc region of an IgG-type antibody. Protein A / G is a combination of binding domains with protein A and protein G. Protein A / G / L is a combination of binding domains with protein A, protein G, and protein L. Protein A, protein G, protein L, protein Z, protein A / G and protein A / G / L share structural similarity.
[0193] The term "instruction materials" includes publications, records, diagrams, website links, or any other media publications that can be used to communicate that one or more compositions of the present invention are useful for their intended use. The instruction materials for the kit of the present invention can be, for example, attached to a container containing the composition or components, or shipped with the container containing the composition or components. Alternatively, the instruction materials can be shipped separately from the container, with the intention that the instruction materials and the composition or components are used in conjunction with the recipient.
[0194] The term "label" refers to a molecule that produces or can be induced to produce a detectable signal. In some embodiments, the label produces a signal for detecting adjacent biomolecules. Examples of labels that can be used include avidin labels, neutravidin labels, or streptavidin labels to detect biotin tags.
[0195] The term "linker" refers to a structure that connects two or more substructures. A linker has at least one uninterrupted chain of atoms extending between the substructures. The atoms of the linker are connected by chemical bonds (usually covalent bonds).
[0196] The phrases "bound to", "coupled to", "conjugated to", "conjugable to", "attached to", and "linked to" refer to direct or indirect binding / conjugation / attachment / linking. For example, the decoy molecule can be directly bound to the photoreactive moiety without the need for an intervening atom, group, or moiety; alternatively, it can be indirectly bound to the photoreactive moiety via one or more intervening atoms, groups, moieties, or linkers. The intervening atoms, groups, moieties, or linkers can include, for example, one or more non-carbon atoms, groups, or moieties, or unsubstituted or substituted alkylene or alkene groups, which can include amine, amide, ether, ester, or thioester linkages, and optionally interrupted by one or more heteroatoms and / or rings, including optionally substituted aromatic rings.
[0197] The term "mass spectrometer" refers to an instrument used to measure the mass-to-charge ratio of one or more molecules in a sample. A mass spectrometer typically includes an ion source and a mass analyzer. Examples of mass spectrometers include matrix-assisted laser desorption ionization (MALDI), continuous or pulsed electrospray (ES) ionization, ion spray, magnetic sector, thermospray, time-of-flight, and massive cluster impact mass spectrometry.
[0198] The term "mass spectrometry" refers to the detection of ions in the gas phase using a mass spectrometer.
[0199] The term "mass spectrometry" includes linear time-of-flight (TOF), reflectron time-of-flight, single-segment quadrupole, multi-segment quadrupole, single magnetic sector, multi-segment magnetic sector, Fourier transform, ion cyclotron resonance (ICR), or ion trap.
[0200] The term "photoactivated" or "light activated" refers to the excitation of atoms by radiant energy, such as by a specific wavelength or wavelength range of light, UV light, etc. In some examples, the photoactivated catalyst promotes the formation of a covalent bond between the tagged phenol and the amino acid.
[0201] The term "peptide" refers to a polymer in which monomers are amino acids and the monomers are joined together by amide bonds. Peptides are typically at least 2, at least 5, at least 10, at least 20, at least 50, at least 100, or at least 500 or more amino acids in length.
[0202] The term "photoreactive moiety" refers to a functional moiety that is activated upon exposure to light (e.g., a specific wavelength or wavelength range of light, UV light, etc.). In some examples, the photoreactive moiety can promote covalent bond formation between the target probe and the amino acid or biomolecule.
[0203] The term "neighboring molecule" or neighboring molecule refers to a molecule that is near another molecule (usually a molecule of interest). A neighboring molecule or neighboring molecule may be bound to the molecule of interest (eg, covalently or non-covalently) or may be in proximity without being bound to the molecule of interest.
[0204] The term "prey" refers to the binding partner of the bait molecule. For example, if an antibody is a bait, the corresponding protein that binds to the antibody is the corresponding prey. In some embodiments, the bait can bind to a single prey. In some embodiments, the bait can bind to more than one prey.
[0205] The term "protein tag" refers to a peptide sequence of amino acids. Protein tags can generally be conjugated to a label. An example of a protein tag is a "self-labeling" tag. Examples of self-labeling tags include BL-tags, CLIP-tags, covalent TMP tags, halogen tags, and SNAP-tags. The SNAP-tag is a ~20 kDa variant of the DNA repair protein O6-alkylguanine-DNA alkyltransferase that specifically recognizes and rapidly reacts with benzylguanine (BG) derivatives. During the labeling reaction, the benzyl moiety is covalently attached to the SNAP-tag, releasing guanine. The CLIP-tag is a variant of the SNAP-tag that is configured to react specifically with O2-benzylcytosine (BC) derivatives rather than benzylguanine (BG).
[0206] The term "secondary antibody" refers to an antibody that specifically recognizes a region of another antibody. Secondary antibodies usually recognize the Fc region of an antibody of a specific isotype. Secondary antibodies can also recognize Fc from one or more specific species.
[0207] The term "small molecule" refers to low molecular weight molecules, including carbohydrates, drugs, enzyme inhibitors, lipids, metabolites, monosaccharides, natural products, nucleic acids, peptides, peptidomimetics, second messengers, small organic molecules and xenobiotics. Small molecules generally have a molecular weight of less than (about) 1000 or less than about 500. Small molecules can be drug molecules. Drug molecules that can be used herein are molecules that are originally intended for diagnosis, cure, mitigation, treatment or preventive measures.
[0208] The term "tag" refers to a functional group, compound, molecule, substituent or the like that enables detection of a target molecule or other molecule. A tag enables a detectable biological or physiochemical signal to be detected by any means, such as absorbance, chemiluminescence, colorimetry, fluorescence, luminescence, magnetic resonance, phosphorescence, and radioactivity. The detectable signal provided by the tag may be directly detectable due to the biochemical or physiochemical properties of the tag portion (e.g., a luminophore tag) or indirectly detectable due to the interaction of the tag with another compound or agent. Tags are typically small functional groups or small organic compounds, such as biotin, desthiobiotin, and the like. In some embodiments, the tag used has a molecular weight of less than about 1,000 Da, 750 Da, 500 Da, or even less.
[0209] The term "tag" refers to the process of adding a tag to a functional group, compound, molecule, substituent or the like. Tagmentation generally enables detection of the target molecule.
[0210] The term "tyramide signal amplification (TSA)" refers to catalyzed reporter deposition (CARD), an enzyme-mediated detection method that utilizes the catalytic activity of an enzyme (e.g., horseradish peroxidase) to catalyze the conversion of inactive tyramide to highly active tyramide. Amplification can occur in the presence of low concentrations of hydrogen peroxide (H2O2). In some examples, tyramide can be labeled with a detectable marker, such as fluorescein (e.g., biotin or 2,4-dinitrophenol (DNP)).
[0211] Unless otherwise indicated, the practice of the techniques described herein may employ conventional techniques and descriptions of chemistry, biochemistry, cell biology, immunology, molecular biology (including cell culture, recombinant techniques, sequencing techniques), and organic chemistry techniques as explained in the literature in the art (e.g., Molecular Cloning: A Laboratory Manual, Fourth Edition, Green and Sambrook, eds., Cold Spring Harbor Laboratory Press, Cold Spring Harbor 2014, and revised and updated editions thereof; John D. Roberts and Marjorie C. Caserio (1977) Basic Principles of Organic Chemistry, second edition. WA Benjamin, Inc., Menlo Park, CA.).
[0212] Set
[0213] The present invention describes kits that can be used to implement the methods described herein, such as for analyzing, labeling, marking biomolecules, identifying and / or isolating one or more biomarkers (e.g., adjacent or neighboring molecules), predicting biomarkers, and identifying lists of biomarkers. The kits can include photoreactive probes and / or target probes. The kits can include additional components to facilitate the specific application for which the kit is designed. Thus, for example, the kit may additionally contain materials useful for detecting a sample and / or detecting a label (e.g., an enzyme substrate for an enzyme label, a filter set for detecting a fluorescent label, an enzyme or related detection reagent, including reagents for performing catalyzed reporter deposition (CARD) or signal amplification (e.g., biotin binding proteins (such as avidin, neutravidin, streptavidin), HRP, tyramide, hydrogen peroxide, etc.). The kit may also include a wash solution for one or more steps (e.g., after sample fixation), such as a blocking agent, a detergent, a salt (e.g., sodium chloride, potassium chloride, phosphate buffered saline (PBS)). The kit may include variations of the wash solution (such as a wash buffer concentrate configured to be diluted prior to use or components for making one or more wash solutions) and other reagents routinely used to perform a particular method. The kit may include a fixative and other sample preparation materials (e.g., ethanol, methanol, formalin, paraffin, etc.).
[0214] The kit may include instructional materials that disclose methods for producing or modifying one or more probes, such as methods for attaching a bait molecule to a photoreactive moiety to prepare a photoreactive probe, applying the photoreactive probe to a sample, conjugating the bait molecule of the photoreactive probe to a prey molecule (in the sample), removing (washing out) the unconjugated photoreactive probe from the sample, applying a labeled target probe (also referred to herein as a primary target probe) to the sample, photoactivating the photoreactive probe to allow the labeled target probe to bind to a molecule of interest, removing (washing out) the unbound target probe, and applying a label to the sample. The kit may also or alternatively include instructional materials that teach the use of the photoreactive probe, target probe, label and wash solutions, and the like.
[0215] The photoreactive kits described herein can be advantageously used with a microscope system, such as the systems described herein and in U.S. Patent Publication No. 2018 / 0367717A1, capable of automatically labeling cellular biomolecules that are adjacent to a biomolecule of interest. The labeled molecules can be directly adjacent to the biomolecule of interest or can be close but not directly adjacent, such as when an intermediary molecule is present between the biomolecule of interest and the cellular biomolecule for capture or analysis. Molecules that are close but not adjacent to the molecule of interest can be part of a cellular structure or contribute to a cellular microenvironment of interest. Figure 1 Schematic diagram showing the photoselective spatial tagging and labeling that can be used for biomolecules. Figure 1The lower portion of the is a substrate 106 (such as a microscope stage) and a number of cells 108 arranged in a monolayer on the substrate 106. In some embodiments, the surface of the entire substrate or a portion of the substrate can be analyzed using an automated microscope system to identify areas of interest. For example, the sample can be stained or labeled to identify areas of interest. Figure 1 The upper portion of the diagram shows a magnified view of one of the cells 108a of a number of cells 108. The cell 108a has a nucleus 116 and a number of different types of organelles 112, such as a cell membrane, mitochondria, ribosomes, and vacuoles. The microscope system 102 selectively illuminates a region of interest (ROI) 118 with narrow-band light 104 to analyze the region of interest 118. The light may be illuminated in the selected region, while cells and substrates in other (and larger) regions 114 are not illuminated. As explained in more detail below, the narrow-band light 104 activates the photoreactive probe to allow the target probe to bind to the biological sample only in the region of interest 118.
[0216] The photoreactive probe can be represented by formula (I):
[0217] (I)GCB(I)
[0218] Wherein part C comprises a chemical bond or linker, part B comprises a photoreactive part bound to part C; and part G comprises a decoy molecule bound to part C and configured to be conjugated with a biological sample.
[0219] In some specific examples, the photoreactive probe can have formula (IA):
[0220] GK 2 -K 1 -B(IA)
[0221] The linker C of the photoreactive probe includes a K 1 part and K in the terminal region of the linker 2 part, wherein the photoreactive part B is connected to the linker (K 1 ) and the bait molecule G is bound to the linker (K 2 )'s terminal region.
[0222] Figure 2A A photoreactive probe 205 having a decoy molecule 251 conjugated to a photoreactive moiety 253 is illustrated. Figure 2B A target probe 206 (also sometimes referred to herein as a primary target probe) having a tag portion 261 and a target portion 263 is illustrated. Figure 2C A target probe with a desthiobiotin tag and a phenol target moiety is shown. Figure 2A and 2CThe bait molecule 251, tag moiety 261, and target moiety 263 (desthiobiotin and phenol) are shown separately (together), as an antibody (such as a secondary antibody), but any bait molecule, tag moiety, and target moiety as described herein may be used. Figure 2D A target probe 236 having a biotin tag 226 and an activated phenol group 243' is illustrated. Figure 2D Exemplifying the target probe after light illumination of the photoreactive probe (probe 205), which in turn activates the phenol group of the target probe, such as in Figure 2C The phenol group shown in , thereby allowing the activated target probe to have a phenol group with a free radical (e.g., a reactive group). The free radical is particularly useful for conjugating to nearby proteins. The biotin tag 226 (or another tag) can be used later to isolate or enrich the tagged adjacent proteins attached thereto. For example, when the tag 226 is biotin, the adjacent proteins can be isolated or enriched by using a biotin-avidin affinity technique (biotin-biotin binding protein affinity technique).
[0223] Figure 2E The interaction of a ruthenium photoreactive probe with a target probe having a desthiobiotin tag and a phenol target moiety to achieve labeling of adjacent proteins is exemplified. Figure 2G After reaction with the photoreactive moiety 253' / dashed circle 228 shown in FIG, the benzene is converted into a tyrosyl group, which specifically reacts and conjugates with the nearby amino acid tyrosine residue of the protein.
[0224] Figures 2F to 2G The steps of labeling the biomolecules in the labeled area 228 are illustrated in the figure. Figure 2F It can be seen that after the photoreactive probe 205 is delivered to a sample (such as a cell or organelle sample) and allows detection and binding to a target biological molecule 301 in the sample, such as a primary antibody or a carbohydrate, lipid, nucleic acid or protein (for example, through the bound photoreactive probe 205a), the target probe 206 is added to the sample. Figure 2G Photoexcitation of the photoreactive probe 205 is illustrated to form a photoexcited photoreactive probe 205' having a photoexcited photoreactive portion 253. The photoexcited photoreactive probe 205' is conjugated to the target biomolecule 301 and allows (arrow 254) the target probe 206 to bind to an adjacent molecule after photoexcitation of the photoreactive probe 205 conjugated to the target biomolecule 301. Figure 2GThe tag portion 261 of the target probe 206 is shown bound to a molecule such as a neighboring molecule 261, and for clarity, the rest of the probe 206 (including the target portion 263) is not shown but present). Although this example shows a primary antibody 216 that recognizes and attaches to a target biomolecule 301 of interest, other photoreactive probes 205 with other decoy molecules 251 can detect and bind to any target as described herein. The target probe 206 contains a tag portion 261 that can be detected using the methods described herein. For example, if the tag portion 261 is a biotin derivative (including biotin), it can be detected using at least one biotin binding protein (avidin, streptavidin and / or neutravidin) detection method. In some examples, this light-assisted enzyme labeling method can advantageously significantly reduce background noise, label cytoplasmic organelles with higher resolution and finer details, and reach subcellular protein bodies without tyramide signal amplification by means of a selective photocatalytic probe (probe 205).
[0225] Figure 2H An example of a marking system 207 is shown, which can be used with Figure 2B The target probe 206 shown in FIG. 2 is used together with the target probe 206 to label the biomolecule adjacent to the target biomolecule of interest. The labeling system 207 includes a labeling complex 271 having a linker 272 and an enzyme or catalyst 274 and an attached target probe 278 . Figure 2H A fluorescent linker portion 284 is also shown. When the tag portion 261 of the target probe 206 has a high affinity to the linker, the fluorescent linker portion 284 can be used to identify the region labeled with the target probe 206. Although this example shows a fluorescent linker portion 284, linkers with or without luminophores can be used. In some embodiments, the linker 272 can be a biotin-binding protein-dye conjugate (avidin-dye conjugate, streptavidin-dye conjugate, neutravidin-dye conjugate) or the like, and the enzyme or catalyst 274 can be a tag-peroxidase and utilize peroxide (not shown) for activity. Figure 2H A tag 282 (such as biotin) is also shown and can be used to conjugate an enzyme or catalyst 274 to the linker 272 (e.g., a biotin binding protein such as avidin). After the tag (biotin) 282-enzyme 274 complex is conjugated to the linker 272, which in turn is conjugated to the protein labeled with the target probe 206, the enzyme or catalyst 274 can be used to catalyze a proximity reaction that allows the attached target probe to be activated, thereby labeling the protein in the vicinity of the biotin 282-enzyme 274 complex. In this example, the target probe 206 and the attached target probe 278 may be the same or different molecules.
[0226] Figure 2HThe connector 272 and the label portion 261 are shown ( Figure 2B ) recognize each other and conjugate together. The enzyme or catalyst 274 can activate the additional target probe 278, and once activated, the activated target probe 278 (e.g., tyramide probe) can bind and detectably label the biomolecules in its vicinity. The additional target probe 278 can include a label portion and a target portion, and can be the same or different from the target probe 206. Any label portion and / or target portion described herein for the main target probe 206 can also be used in the additional target probe 278.
[0227] Fig.2I Relatively direct photochemical labeling (top figure, labeled as Method II) and light-assisted enzymatic labeling (bottom figure, labeled as Method III) using the photoreactive kits and systems described herein are shown to label biomolecules in a small region of interest (ROI) on a sample having biomolecules (I). Prior to performing Method II or Method III, a sample (e.g., a cell or tissue sample) containing a biomolecule of interest 210 (proteins are used herein as examples, but other biomolecules may be analyzed instead) is analyzed and the region of interest is identified. The sample may be pre-treated, such as fixed and stained. For example, the sample may be fixed and stained with a cell stain (e.g., hematoxylin and eosin (H&E); Masson's trichrome stain), an immunofluorescently labeled antibody to identify the protein of interest, or identified by other methods. Once the region of interest is identified, the methods and systems described herein may be used to analyze complexes of adjacent biomolecules within the region of interest. As Fig.2I As exemplified in method II of , a sample may be treated with a direct photoreactive probe 212, and light directed to a region of interest of the sample (also referred to as patterned light) may activate the direct photoreactive probe 212 to form an activated direct photoreactive probe 212'. The activated direct photoreactive probe 212' is capable of forming a complex with other molecules in close proximity (shown as a dotted circle in method II). The activated direct photoreactive probe 212' may diffuse and label neighboring molecules 211 near the molecule of interest 210. However, the labeling diameter (300 to 600 nm) of the photoactivation of the direct photoreactive probe is spatially limited by the diffraction limit of the light source used. In addition, because the direct photoreactive probe can diffuse freely, any protein in the path of the direct photoreactive probe (e.g., in the path of the patterned light) may be labeled. Method II also shows that it labels more distant biomolecules 231. The region labeled or the precision of labeling by the activated direct photoreactive probe 212' covers an area of about 300 to 600 nm. This region may include biomolecules that are not immediately adjacent to the protein of interest and, in some instances, may lead to confusing, misleading, or unhelpful results.
[0228] In contrast, in Fig.2I In method III shown in the lower part of FIG. 1 , the photoreactive moiety 253 is pre-conjugated with the bait molecule 251 to form the photoreactive probe 205 (see Figure 2A ). The photoreactive moiety 253 may be pre-conjugated to the decoy molecule 251, such as by covalent bonding with or without a linker, such as the linker shown in FIG. Fig.2I As exemplified in method III of , the photoreactive probe 205 is delivered to a sample (specimen) on a substrate 209 and the bait molecule 251 (as part of the photoreactive probe 205) recognizes the corresponding biomolecule of interest (eg, target or prey). Fig.2I As illustrated in step (i) of , patterned light is also directed to the sample in a selected location (region of interest). However, the patterned light here activates the photoreactive portion 253 of the photoreactive probe 205', which is now attached to the biomolecule of interest (e.g., target or prey), and the activated photoreactive probe 205' can promote the target portion 263 of the primary target probe 206 to form a covalent bond with a molecule or moiety in the nearby sample. In addition to the patterned light being directed to only a limited photoactivation area, the easily accessible target probe 206 is activated only within a limited catalyst radius (e.g., within the reaction range of the photoreactive portion, such as shown by the labeled area 228) and has sufficient reactivity to make it unlikely to undergo long-range diffusion after activation and thus cause the primary target probe 206 to become covalently bound to neighboring molecules 211 and 214. Step (i) also shows how background or unwanted labeling can be reduced using the probes and methods described herein. In step (i), the photoreactive probe 205a is attached to the biomolecule; however, because the photoreactive probe 205 is outside the light transmission area (patterned light area), the photoreactive probe 205a is not activated, and the target probe 206 and the molecule outside the light transmission area are not bonded.
[0229] The unbound target probes are washed out with a washing solution. Fig.2I Steps (ii) and (iii) show the use of Figure 2H The labeling system 207 shown in the figure labels molecules near the molecule of interest 210. Other labeling systems may also be used. By way of example, the linker 272 of the labeling system 271 is conjugated to the tag portion 261 of the labeled biomolecule 206 (211), and the enzyme or catalyst 274 activates the attached target probe 278 to form an activated target probe 278'. The activated attached target probe 278' binds to the adjacent molecule 211 (see Fig.2IBecause the photoreactive probe 205' is attached to the molecule of interest 210 and the target probe 206 and the additional target probe 278 do not diffuse very far before reacting, the adjacent molecule 214 is labeled while the more distant molecule 231 is not labeled.
[0230] By photoselectively localizing an enzyme or catalyst 274 (e.g., as part of a labeling system 207) (such as a peroxidase) in the vicinity of the molecule of interest using the labeling and marking just described and labeling adjacent molecules 214 in the region of interest, Fig.2I The catalytic reaction of 271 described in can be localized in an area as small as <100 nm. In some variations, larger areas may be labeled (e.g., up to about 200 nm, up to about 300 nm, up to about 400 nm, up to about 500 nm, up to about 1 μm, up to about 2 μm, up to about 5 μm). In addition, some molecules of interest in a sample may have multiple small localized areas and thus the photoreactive probe may interact with different molecular complexes containing the same molecule of interest at different locations simultaneously. The optical label may be used continuously at at least one or more locations. For example, in a Fig.2I After applying light as shown in Method III of , light can be selectively applied to a second (third, fourth, etc.) location on the sample and this method can be repeated as many times as desired. In addition to labeling (depositing labels onto) relatively small numbers of adjacent molecules in very small areas of the sample, such as due to the use of microscopic analysis to direct light and the probes described herein and as explained below, the method can also be performed with sufficiently mild or gentle treatments so that the cellular architecture remains intact during the use of the methods herein, advantageously allowing detection of naturally occurring biomolecular interactions.
[0231] Non-limiting examples of bait molecules that can be used herein can include one or more of the following: antibodies, CLIP-tags, halogen tags, SNAP-tags, functional proteins (e.g., protein A, protein G, protein L, protein A / G, protein A / G / L, or protein drugs), immunoglobulin binding peptides, biotin binding proteins (including avidin, streptavidin and / or neutravidin), RNA molecules, small molecules (e.g., erlotinib), nucleic acid molecules, fluorescent in situ hybridization (FISH) probes, fragment antigen binding regions, nanobodies, biopharmaceuticals, and the like. Examples of biopharmaceuticals that can be used as decoys include abatacept (Orencia); abciximab (ReoPro); abobotulinumtoxinA (Dysport); adalimumab (Humira); adalimumab-atto (Amjevita); ado-trastuzumab emtansine (Kadcyla); aflibercept (Eylea); agalsidase beta (Fabrazyme); albiglutide (Tanzeum); aldesleukin (Proleukin); alemtuzumab (Campath, Lemtrada); alglucosidase alpha (Alglucosidase alpha) ... alfa (Myozyme, Lumizyme); alirocumab (Praluent); alteplase, cathflo activase (Activase); anakinra (Kineret); asfotase alfa (Strensiq); asparaginase (Elspar); asparaginase erwinia chrysanthemi (Erwinaze); atezolizumab (Tecentriq); basiliximab (Simulect); becaplermin (Regranex); belatacept (Nulojix); belimumab (Benlysta); bevacizumab (Avastin);bezlotoxumab (Zinplava); blinatumomab (Blincyto); brentuximab vedotin (Adcetris); canakinumab (Ilaris); capromab pendetide (ProstaScint); certolizumab pegol (Cimzia); cetuximab (Erbitux); collagenase (Santyl); collagenase clostridium histolyticum (Xiaflex); daclizumab (Zenapax); daclizumab (Zinbryta); daratumumab (Darzalex); darbepoetin alfa (Darzalex); alfa (Aranesp); denileukin diftitox (Ontak); denosumab (Prolia, Xgeva); dinutuximab (Unituxin); dornase alfa (Pulmozyme); dulaglutide (Trulicity); ecallantide (Kalbitor); eculizumab (Soliris); elosulfase alfa (Vimizim); elotuzumab (Empliciti); epoetin alfa ( alfa (Epogen / Procrit); etanercept (Enbrel); etanercept-szzs (Erelzi); evolocumab (Repatha); filgrastim (Neupogen); filgrastim-sndz (Zarxio); follitropin alpha (Gonal f); galsulfase (Naglazyme); glucarpidase (Voraxaze); golimumab (Simponi); golimumab injection (Simponi Aria);ibritumomab tiuxetan (Zevalin); idarucizumab (Praxbind); idursulfase (Elaprase); incobotulinumtoxinA (Xeomin); infliximab (Remicade); infliximab-dyyb (Inflectra); interferon alfa-2b (Intron A); interferon alfa-n3 (Alferon N injection); interferon beta-1a (Avonex, Rebif); interferon beta-1b (Betaseron, Extavia); interferon gamma-1b (Actimmune); ipilimumab (Yervoy); ixekizumab (Taltz); laronidase (Aldurazyme); mepolizumab (Nucala); methoxypolyethylene glycol-epoetin beta (Mircera); metreleptin (Myalept); natalizumab (Tysabri); necitumumab (Portrazza); nivolumab (Opdivo); obiltoxaximab (Anthim); and obinutuzumab (Gazyva); ocriplasmin (Jetrea); ofatumumab (Arzerra); olaratumab (Lartruvo); omalizumab (Xolair); onabotulinumtoxinA (Botox); oprelvekin (Neumega); palifermin (Kepivance); palivizumab (Synagis); panitumumab (Vectibix); parathyroid hormone (Natpara); pegaspargase (Oncaspar); pegfilgrastim (Neulasta); peginterferon alfa-2a (Pegasys);Pegylated interferon alpha-2b (PegIntron, Sylatron); pegylated interferon beta-1a (Plegridy); pegloticase (Krystexxa); pembrolizumab (Keytruda); pertuzumab (Perjeta); ramucirumab (Cyramza); ranibizumab (Lucentis); rasburicase (Elitek); raxibacumab reslizumab (Cinqair); reteplase (Retavase); rilonacept (Arcalyst); rimabotulinumtoxin B (Myobloc); rituximab (Rituxan); romiplostim (Nplate); sargramostim (Le ukine); sebelipase alfa (Kanuma); secukinumab (Cosentyx); siltuximab (Sylvant); tbo-filgrastim (Granix); tenecteplase (TNKase); tocilizumab (Actemra); trastuzumab (Herceptin); ustekinumab (Stelara); vedolizumab (Entyvio); ziv-aflibercept (Zaltrap). ;
[0232] Non-limiting examples of photoreactive moieties include aryl azides, diphenyl ketones, riboflavin, flavin, photoflavin and / or derivatives thereof, luciferin or derivatives thereof, killer red (photosensitive protein), miniSOG (photosensitive protein), another photosensitive protein (e.g., configured to generate reactive oxygen species (ROS) upon light irradiation), methylene blue or derivatives thereof, phenols, pterin derivatives, derivatives, ruthenium-based photocatalysts, and rose bengal derivatives. Luciferin is a fluorescent organic dye having four negatively charged carboxylic acid groups, and its derivatives are generally configured to retain the active center and may have, for example, additions such as hydrocarbon tails, isothiocyanates, carboxylic acids, or amines. Derivatives of other molecules (unless otherwise specified or clear from the context) generally retain the characteristic function of the molecule, but may be modified in other ways. In some embodiments, a certain number of photoreactive moieties are conjugated to an antibody (or other decoy molecule) to form a photoreactive probe. The number of photoreactive moieties conjugated to an antibody (or other decoy molecule) can range from 1 to 50 (eg, 1, 1 to 5, 1 to 10, 1 to 20, etc.).
[0233] Figures 3A to 3G 3Y to 3AI show examples of photoreactive moieties (eg, 253 photoreactive moieties) that can be used in the photoreactive probes (eg, photoreactive probe 205) described herein. Figures 3A to 3N Display ruthenium-based photocatalyst. Figure 3Y to 3AI , the shaded area shows where the linker (covalent bond) is attached. Fig.3O Displays Rose Bengal derivatives. Figure 3P to Q show luciferin derivatives. Figure 3R Methylene blue derivatives are shown. Figure 3S to T show the luminoflavin derivatives. Figure 3U to 3V Riboflavin and flavin derivatives are shown. Figures 3W to 3X Pterin derivatives are shown. The selection of a particular photoreactive moiety may depend on the desired wavelength and type of decoy molecule. For example, the components of the photoreactive probe and the components used for pre-detection analysis may be selected so as not to interfere with each other (or to minimize interference).
[0234] In some embodiments, the ruthenium-based compound represented by formula (II) can be used as the B part (photoreactive part) of the photoreactive probe represented by formula (I) or (IA):
[0235]
[0236] wherein L1, L2, L3 and L4 are each independently a ligand; and X 1 and X 2 Each is independently a ligand having a reactive portion, wherein the reactive portion can be bound to the C portion of formula (I) as listed above. 1 and X2 may be each independently 3-ethynylpyridine, 3-(bromomethyl)pyridine, maleimide, 4′-methyl-4-carboxybipyridyl-N-succinimide ester, nicotinaldehyde, 1-(4-(pyridin-3-yl)-1H-1,2,3-triazol-1-yl)ethanone, 4-pentynenitrile, 4-aminobutyne or the like; and L 1 With L 2 can be joined to form a first bidentate ligand and L 3 With L 4 The first bidentate ligand and the second bidentate ligand are each independently 2,2'-bipyridyl (bpy), 4'-methyl-4-carboxyl bipyridyl-N-succinimide ester, 4,4'-dicyano-5,5'-dimethyl-2,2'-bipyridyl (CN-Me-bpy), 4,4'-dimethyl-2,2'-bipyridyl (dmb), 4,4'-di-tert-butyl-2,2'-bipyridyl (dbpy), 4,4',5,5'-tetramethyl-2 ,2'-bipyridine (tmb), 2-phenylpyridine (ppy), 6-bromo-2,2'-bipyridine, 6,6'-dibromo-2,2'-bipyridine, 5-bromo-2,2'-bipyridine, 6-amino-2,2'-bipyridine, 6,6'-diamino-2,2'-bipyridine, 2,2'-bipyridine-6-carbonitrile, 2,2'-bipyridine-6,6'-bis(carbonitrile), 2,2'-bipyridine-6-carboxylic acid, 2,2'-bipyridine-6,6'-dicarboxylic acid, bisquinoline or the like. Accordingly, the ruthenium-based compound of formula (II) may be [Ru(bpy) 2 (methyl-bpy-NHS)] 2+ 、[Ru(bpy) 2 (bpy-(NHS)2)] 2+ 、[Ru(bpy) 2 (methyl-bpy-(CH2)3-NHS)] 2+ 、[Ru(bpy) 2 (bpy-((CH2) 3 -NHS) 2 ] 2+ , Sulfo-labeled NHS-ester, [Ru(bpy) 2 (methyl-bpy-COOH)] 2+ 、[Ru(bpy) 2 (bpy-(COOH) 2 )] 2+ 、[Ru(bpy) 2 (Methyl-bpy-(CH 2 ) 3 COOH)] 2+ 、[Ru(bpy)2 (bpy-((CH2)3COOH)) 2 ] 2+ , their salts (e.g., bis(hexafluorophosphate)), or any combination thereof. The NHS-ester group may be replaced by a chemical group such as maleimide, iodoacetyl, cysteine / thiol, click chemistry, or the like. The carboxyl group may be replaced by a chemical group such as maleimide, iodoacetyl, cysteine / thiol, click chemistry, or the like. The click chemistry group may be an alkyne, BCN, DBCO, N 3 In a specific embodiment, the ruthenium compound of formula (II) is selected from the group consisting of: [Ru(bpy) 2 (isothiocyanato-phenanthroline)] 2+ 、[Ru(bpy) 2 (aminophenazone)] 2+ 、[Ru(bipyridine) 2 (3-Ethynyl-pyridine) 2 ]+、Ru(bipyridine) 2 (3-ethynylpyridine) 2 Cl 2 、Ru(bipyridine) 2 (3-ethynylpyridine) 2 (PF 6 ) 2 、[Ru(bisquinoline) 2 (4-Pentynenitrile) 2 ]+、Ru(Bisquinoline) 2 (4-Pentynenitrile) 2 Cl 2 、Ru(Bisquinoline) 2 (4-Pentynenitrile) 2 (PF6) 2 、[Ru(bipyridine) 2 (4-Aminobutyne) 2 ] + 、[Ru(bipyridine) 2 (4-Pentynenitrile) 2 ] + 、[Ru(bipyridine) 2 (Nicotinaldehyde) 2 ] + 、[Ru(bipyridine)2(1-(4-(pyridin-3-yl)-1H-1,2,3-triazol-1-yl)ethanone) 2 ] + 、[Ru(bipyridine) 2 (3-(Bromomethyl)pyridine) 2 ] + 、[Ru(bipyridine)2(maleimide)2 ] + 、Ru(4,4-dicarboxylic acid-2,2'-bipyridine)(4,4'-bis(p-hexyloxyphenylvinyl)-2,2-bipyridine)(NCS) 2 , cis-bis(isothiocyanato)bis(2,2'-bipyridyl-4,4'-dicarboxylate)ruthenium(II), cis-bis(2,2'-bipyridyl)dichlororuthenium(II) hydrate, bis(4,4-dicarboxy-2,2-bipyridyl)dichlororuthenium(II), di-tetrabutylammonium cis-bis(isothiocyanato)bis(2,2'-bipyridyl-4,4'-dicarboxylate)ruthenium(II), their salts, their stereoisomers or their tautomers and any combination thereof.
[0237] Figures 4A to 4L Exemplary parts of the C (linker) part in the photoreactive probe represented by formula (I) listed above are shown. Regarding the C part of the photoreactive probe, some embodiments can use, for example, NHS-BCN, NHS-(PEG) n -BCN, NHS-DBCO, NHS-(PEG) n -DBCO, NHS-alkyne, NHS-(PEG) n -Alkyne, NHS-N 3 、NHS-(PEG) n -N 3 , NHS-maleimide, NHS-(PEG) n -Maleimide, NHS-iodoacetyl, NHS-(PEG) n -Iodoacetyl, NHS-cysteine / thiol, NHS-(PEG) n -Cysteine / thiol, maleimide-peptide / amino acid, maleimide-(PEG) n -Peptide / amino acid, maleimide-oligonucleotide, iodoacetyl-peptide / amino acid, iodoacetyl-(PEG) n -peptide / amino acid, iodoacetyl-oligonucleotide or the like as a linker, wherein each n can independently be an integer from 1 to 20. In some embodiments, the linker includes (PEG) n , peptide, amino acid or oligonucleotide, and wherein each n can independently be an integer from 1 to 20. Other examples of polymeric linkers include other polyethylene glycols (PEG), polypropylene glycols, polyethylene, polypropylene, polyamides and polyesters. The linker can be a linear molecule having at least one or two atoms in the chain, and can include more.
[0238] Figures 5A to 5KExamples of labeling moieties that can be used in the target probes described herein are shown. Labeling moieties (sometimes also referred to herein as "tags") are configured to interact with a detectable label to label a biomolecule adjacent to a molecule of interest (first molecule) and produce a detectable label. Figures 5A to 5E Examples of click chemistry tags that can be used with the probe are shown. The click chemistry tag can be, for example, an azide moiety or an alkyne moiety. Figures 5F to 5H Shown are examples of biotin derivatives that can be used as probe tags in target probes. Fig.5I Displays the Digoxin section label. Figure 5J Peptide labels are shown. Figure 5J In particular a poly-His tag with 6 histidines is shown (SEQ ID NO. 1). However, the histidine tag may alternatively comprise fewer or more histidines, such as 5 histidines or 7 to 10 histidines or more than 10 histidines. Figure 5K SNAP-tags are shown. In some cases, CLIP-tags, oligonucleotides or halo-tags may also be used.
[0239] Figures 6A to 6L Examples of targeting moieties that can be used in the targeting probes described herein (e.g., together with labeling moieties) are shown, such as in Figure 2B . Upon photoactivation of a photoreactive probe (e.g., photoreactive probe 205), the activated photoreactive probe can generate a reactive intermediate (such as a free radical) from a target portion 263 of the target probe 206 and the target portion 263 can form a covalent bond with an amino acid or other biomolecule adjacent thereto (e.g., an adjacent molecule, such as adjacent molecule 211). The amino acid can be alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, or the like. In some variations, the target portion can form a bond with an adjacent carbohydrate, lipid, or nucleic acid.
[0240] In the implementation of the photocatalytic ruthenium complex-antibody conjugate as the photoreactive probe 205, bis(2,2′-bipyridine)-4′-methyl-4-carboxybipyridine-ruthenium can be specifically conjugated to a secondary antibody via an NHS-amide linkage, and the secondary antibody can selectively hybridize with the primary antibody of the region of interest (ROI) (see, e.g. Figure 2E to 2E ). [Ru(bpy) 3 ] 2+ It is a photocatalyst that can be excited by single-photon or two-photon irradiation of light at about 425nm and 780nm, respectively. The obtained oxidized [Ru(bpy) 3 ] 3+can abstract electrons from the phenolic hydroxyl group of biotin-phenol as a target probe (see, e.g. Figure 2B ), and generate phenoxy radicals and protons to adjacent tyrosine residues. To achieve higher density labeling for omics studies (such as proteomic profiling), HRP amplification can be used to further covalently bind the tyramide groups to tyrosine residues near neighboring molecules of the protein, followed by streptavidin enrichment and enzymatic digestion on magnetic beads. Finally, subcellular / localized proteomic profiling can be obtained by performing quantitative proteomic analysis on the sample, such as after removal from a microscope slide. The implementation is characterized by an antibody-based ruthenium complex ([Ru(bpy) 3 ] 2+ )-antibody conjugates that serve as selective and photocatalytic probes for spatial and localized proteomic analysis, identification of novel proteins that cannot be fractionated or isolated by conventional methods in organelles, and size- and morphology-distinguishable labeling via single- or two-photon illumination.
[0241] In some embodiments, the present invention describes a photoreactive kit comprising at least one of a photoreactive probe and a primary target probe or both a photoreactive probe and a primary target probe. In this and other embodiments, the photoreactive probe can be represented by formula (I): GCB (I), wherein the C portion is a single chemical bond or linker; the B portion includes a photoreactive portion bound to the C portion; and the G portion includes a decoy molecule bound to the C portion. In this and other embodiments, the primary target probe includes a detectable label and a target portion. The primary target probe may include a detectable label bound to a photoexcitable target portion. In some embodiments, the decoy molecule of the photoreactive probe is configured to be conjugated to a first molecule in a biological sample, and when the photoreactive probe is photoactivated and the primary target probe acts through the photoactivated probe to form a photoexcited primary target probe, the photoexcited primary target probe is configured to form a covalent bond with a target molecule in the biological sample. In some embodiments, the first molecule and the target molecule are different entities. In some embodiments, the first molecule and the target molecule are the same entity. The first molecule disclosed herein may also be referred to as or applicable to the target molecule, unless the context indicates otherwise.
[0242] Photoselective labeling and labeling as described herein can be performed in various sample types, such as samples obtained from tissues, cells or particles, such as samples from entities (e.g., human individuals, mouse individuals, rat individuals, insect individuals, plants, fungi, microorganisms, viruses) or tissue samples or cell samples not from organisms, such as cell culture samples or artificial tissue scaffold samples (e.g., cultured laboratory cells, heart tissue developed in vitro, 3D printed tissues, etc.). The samples analyzed using the probes, materials and methods described herein may be alive (living cells) or may not be alive (e.g., fixed cells). Samples for labeling and labeling may include monolayer samples, multilayer samples, samples fixed to substrates (e.g., microscope slides), samples not fixed to substrates, cell suspensions or extracts, such as in vitro cell extracts, reconstructed cell extracts or synthetic extracts. In some embodiments, the sample is not fixed (unfixed). Examples of probes for labeling living cells include probes using small molecules or probes sometimes referred to as self-labeled molecules (e.g., CLIP-tags, halogen tags, SNAP-tags). In some embodiments, a large number of cells can be analyzed automatically using the methods and materials described herein (e.g., at least about 1,000 cells, at least 10,000 cells, at least 100,000 cells, at least 1 million cells). In some embodiments, a smaller number of cells, such as no more than 1,000 cells, no more than 100 cells, or only a few cells or a single cell, can be analyzed. In some embodiments, the sample is fixed. For example, a cell or tissue sample can be fixed with, for example, acetic acid, acetone, formaldehyde (4%), formalin (10%), methanol, glutaraldehyde, or picric acid. The fixative can be a relatively strong fixative and can cross-link molecules, or it can be a weaker fixative and does not cross-link molecules. The cell or tissue sample for analysis can be frozen before analysis, such as using dry ice or quick freezing. The cell or tissue sample can be embedded in a solid material or a semi-solid material, such as paraffin or a resin, before analysis. In some embodiments, the cell or tissue sample to be analyzed can be fixed and then embedded, such as formalin fixation and paraffin embedding (FFPE). The bait portion of the (photoreactive probe) can be one or more of a nucleic acid, a protein, and a small molecule. The nucleic acid bait portion can be DNA, cDNA, or RNA. The nucleic acid bait portion can be an in situ hybridization probe, such as a fluorescent in situ hybridization probe or a non-fluorescent in situ hybridization probe, such as a chemiluminescent in situ hybridization probe (CISH). An in situ hybridization probe is one or more nucleic acid strands composed of DNA, cDNA, or RNA that contain or are modified to contain a fluorescent or other detectable portion.Fluorescent in situ hybridization probes or non-fluorescent in situ hybridization probes are typically 15 bases to 2,000 bases in length (such as 15 to 30 bp in length, 15 bp to 100 bp in length, 30 bp to 100 bp in length, 100 bp to 1000 bp in length, 500 bp to 200 bp in length, etc.), although they may be longer or shorter. The in situ hybridization bait portion of the (photo-reactive) probe may be used (may be configured) to hybridize with a prey or target. After the in situ hybridization bait portion of the (photo-reactive) probe binds to its prey, the photo-reactive probe may be photoactivated using photoactivation, and the primary target probe may be activated by the photoactivated probe to form a photo-excited primary target probe, and the photo-excited primary target probe may (or be configured) form a covalent bond with a second molecule (third molecule, fourth molecule, etc.) in the biological sample, such as a biomolecule, such as a carbohydrate, lipid, nucleic acid, and protein. In some embodiments, the bait molecule may include a reactive ligand. The reactive ligand can be configured to react with the corresponding molecule in the sample of interest. This reaction can result in a rapid and irreversible binding between the reactive ligand and the corresponding molecule. In some embodiments, the reactive ligand bait molecule can utilize the self-labeling protein (SLP) technology. The self-labeling protein technology is based on the formation of a specific covalent bond between a pair of reactants: a reactive ligand and a fusion protein that is configured (designed) to bind to the ligand. The fusion protein used for the self-labeling protein technology can be a self-labeling protein tag (usually derived from an enzyme) and fused with a protein of interest (POI). Compared with enzyme reactions that increase the rate of chemical reactions without being permanently changed by the reaction itself, the self-labeling protein technology can result in the formation of a specific covalent bond between the ligand and the corresponding fusion protein. Similar to other enzyme reactions, the reaction rate using the self-labeling protein technology is fast and the reaction is very specific. The ligand can label the fusion protein in the self-labeling protein technology without the need for an additional enzyme for labeling. Examples of reactive ligands (in photoreactive probes) used as baits include, but are not limited to, CLIP-tags. TM Ligand (also called CLIP-tag TM Substrate or CLIP-tag TM ), halogen tags Ligand (also called halide tag Substrate or halogen tag ) and SNAP-Tag Ligand (also called SNAP-tag Substance or SNAP-Tag ). Using SNAP-Tag as bait Examples of ligands are benzylguanine (BG) derivatives and examples of corresponding fusion proteins are derivatives of the 20 kDa DNA repair protein O6-alkylguanine-DNA alkyltransferase (hATG) (e.g., the self-labeling protein SNAP-tag protein moiety), which react specifically and rapidly with benzylguanine (BG) derivatives and are fused to the protein of interest. SNAP-tag The reaction releases chemically inert guanine, and this system (and other self-labeling protein systems) can be safely used with living cells, in addition to other samples such as non-living (fixed) cells, cell extracts or other tissue extracts. CLIP-tags that can be used as bait TM Examples of ligands are benzylcytosine (BC) derivatives, such as O2-benzylcytosine with a cytosine leaving group via a benzyl linker. Examples of corresponding fusion proteins are derivatives of the 20 kDa DNA repair protein O6-alkylguanine-DNA alkyltransferase (hATG) (e.g., the self-labeling protein CLIP-tag protein moiety), which react specifically and rapidly with benzylcytosine (BC) derivatives and fuse to the protein of interest. Halo tags that can be used as baits An example of a ligand that is a reactive haloalkane (e.g., chloroalkane) derivative and the corresponding fusion protein is a modified version of a bacterial dehalogenase enzyme (e.g., a self-labeled protein halo-tagged protein moiety) that removes the halogen of an aliphatic hydrocarbon molecule, such as by a fused nucleophilic aspartate residue, and is fused to a protein of interest. The reactive ligand decoy molecule that is part of some photoreactive probes is bound to the photoreactive moiety of the photoreactive probe (e.g., the "G" moiety in GCB photoreactive probes, G-K2-K1-B photoreactive probes, etc.) via a photoreactive probe linker (or a single chemical bond). The protein of interest may be an endogenous protein or a non-endogenous protein (antibodies, structural proteins, etc.). Fusion proteins with the protein of interest may be tagged with a self-labeled protein moiety (CLIP-tagged protein moiety, halo-tagged protein moiety, SLIP-tagged protein moiety), and expressed using standard recombinant protein expression techniques and used as described herein. The cells may be genetically modified with a nucleic acid comprising a nucleotide sequence encoding the fusion protein and analyzed directly, or the fusion protein may be expressed and added to a sample, such as a cell sample, a cell extract sample, a tissue extract sample, etc. In some variations, the self-tagged protein may include a post-translational modification tag moiety or a non-covalent protein moiety attached to the protein of interest, rather than a fusion protein.
[0243] The prey of the in situ hybridization bait portion can be a target DNA, target cDNA, or target RNA, such as a portion of a genome (e.g., chromosome, expressed RNA, rRNA, etc.) in a cell, cell extract, or other tissue extract.
[0244] The concentration of the photoreactive probe may range from 0.1 μg / mL to 100 μg / mL, and the concentration of the target probe may range from 1 μM to 20 mM. In some embodiments, the wavelength of light used for activation of the photoreactive probe or photoselective tagging and labeling ranges from about 200 nm to about 1600 nm, for example, from about 200 nm to about 250 nm, from about 250 nm to about 300 nm, from about 300 nm to about 350 nm, from about 350 nm to about 400 nm, from about 400 nm to about 450 nm, from about 450 nm to about 500 nm, from about 500 nm to about 550 nm, from about 550 nm to about 600 nm, from about 600 nm to about 650 nm, from about 650 nm to about 700 nm. About 700nm, about 700nm to about 750nm, about 750nm to about 800nm, about 800nm to about 850nm, about 850nm to about 900nm, about 900nm to about 950nm, about 950nm to about 1000nm, about 1000nm to about 1100nm, about 1100nm to about 1200nm, about 1200nm to about 1300nm, about 1300nm to about 1400nm, about 1400nm to about 1500nm or about 1500nm to about 1600nm. In some embodiments, the wavelength range of light used to perform photoselective tagging and labeling is about 700nm to about 1600nm (near infrared light) (e.g., 780nm) in a two-photon light source; or the wavelength range of light is about 300nm to about 650nm or to about 700nm (visible light) (e.g., 360nm, 405nm, 425nm) in a single-photon light source. The wavelength of light used for photoactivation of the photoreactive probe is typically different from the wavelength of light used for imaging. In some embodiments, activation of the photoreactive probe utilizes light radiation (light) of about 300 to 450 nm, 550 nm for single photon activation or >720 nm for multiphoton activation. The specific wavelength depends on the specific photoreactive moiety of the photoreactive probe.
[0245] method
[0246] Also disclosed herein are methods and analytical methods for photoselectively labeling and marking biomolecules. The methods can be used to label and / or label carbohydrates, lipids, nucleic acids, proteins, either alone or in combination. The methods may include the following steps: treating a biological sample (subjecting the biological sample) with a photoreactive probe having a bait molecule and a photoreactive portion and binding the bait molecule to a first molecule (i.e., prey) in the biological sample. In some embodiments, the biological sample comprises a certain number of cells. In some embodiments, the biological sample comprises a certain number of living cells. In some embodiments, the biological sample comprises at least 1, at least 100, at least 1000, or at least 10,000 living cells. In some embodiments, the biological sample comprises a cell extract. In some embodiments, the photoreactive portion is coupled to the bait molecule by a chemical bond or linker. In some embodiments, the photoreactive probe and the first molecule form a probe-first molecule complex or molecule that is non-covalently conjugated. In some embodiments, the bait molecule comprises an antibody, a CLIP-tag, a halogen tag, a SNAP-tag, protein A, protein G, protein L, protein A / G, protein A / G / L, an immunoglobulin binding peptide, a biotin binding protein (such as avidin, streptavidin, neutravidin), an RNA molecule, a small molecule, a nucleic acid molecule, a fluorescent in situ hybridization (FISH) probe, a fragment antigen binding region, or a nanobody. In some embodiments, the photoreactive moiety or photoreactive probe comprises a ruthenium-based photocatalyst, an iridium-based photocatalyst, a Bengal rose red derivative, a fluorescein derivative, a methylene blue derivative, a flavin derivative, a photoflavin, a riboflavin, a pterin derivative, a photosensitive protein, miniSOG, killer red, a phenol, an aryl azide, or a diphenyl ketone.
[0247] The method may include the step of illuminating the biological sample with an imaging light source of an image-guided microscope system. The method may include the step of imaging the illuminated sample with a camera. The method may include the step of acquiring at least one subcellular morphological image of the sample in a first field of view with a camera. The method may include the step of processing at least one image and determining a region of interest in the sample based on the processed image. The method may include the step of obtaining coordinate information of the region of interest.
[0248] The method may include a step of delivering the target probe to the biological sample. The method may include a step of selectively illuminating the region of interest with light based on the obtained coordinate information, thereby activating the photoreactive portion, resulting in the formation of a covalent bond between the target probe and the adjacent molecule or the molecule of interest in the biological sample of the region of interest in the biological sample. The method may include a step of removing the unconjugated photoreactive probe from the biological sample, thereby allowing the photoreactive probe to guide the selective illumination of the selected region of interest. In some embodiments, the step of selectively illuminating includes illuminating the region of 25μs / pixel to 400μs / pixel, 50μs / pixel to 300μs / pixel, 75μs / pixel to 200μs / pixel, or 400us / pixel to 5000us / pixel. In some embodiments, the primary target probe includes a label portion and a target portion. In some embodiments, the label portion of the primary target probe includes a biotin derivative, a click chemistry label, a halogen label, a SNAP-label, a CLIP-label, digoxigenin, a nucleic acid label, or a peptide label. In some embodiments, the click chemistry tag includes an alkyne-based moiety or an azide-based moiety. In some embodiments, the target portion of the target probe is configured to generate a reactive intermediate (e.g., a phenoxy radical, a carbene, or the like) (in a biological sample) that is responsible for forming a covalent bond with an amino acid of a protein adjacent to the molecule of interest. In some embodiments, the activated photoreactive portion can promote the formation of a free radical in the target probe, thereby forming a covalent bond between the photoreactive portion and an amino acid or biomolecule of the biological sample in a selected region of interest. In some embodiments, the amino acid (e.g., an amino acid of a protein of interest or an adjacent protein molecule) can be alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, or the like.
[0249] The method may further include the step of conjugating a detectable label to the target probe and detecting the adjacent molecule (i.e., prey) adjacent to the first molecule with a detectable label activity. In some embodiments, the detectable label includes a catalytic label. In some embodiments, the detectable adjacent label includes a region where the photoselective adjacent label diameter (or the longest dimension) is less than 5 μm, less than 2 μm, less than 1 μm, less than 500nm, less than 300nm, less than 200nm, or less than 100nm. Some embodiments include the step of conjugating a linker to the target probe. In some embodiments, the linker is conjugated to the target probe by the affinity between the linker and the main target probe, so as to identify the position of the biological sample covalently bound to the target probe. Some embodiments additionally include the step of conjugating a label-peroxidase to the linker. In some embodiments, the label-peroxidase is configured to catalyze an additional target probe (e.g., a tyramide probe) to form a covalent bond between the additional target probe and the biological sample. (The target probe may be the first target probe and the additional target probe may be the second target probe.) More specifically, the tag-peroxidase may activate the additional target probe to have a free radical and form a covalent bond between the additional target probe and the tyrosine of the biological sample. Some embodiments further include the step of removing at least the region of interest from the microscope stage. Some embodiments further include the step of subjecting the selectively illuminated sample to mass spectrometry or sequencing analysis.
[0250] Some methods include contacting a biological sample having a target biomolecule with a photoreactive probe as described herein, thereby non-covalently conjugating the set of photoreactive probes to the target biomolecule, washing out the unconjugated photoreactive probes, spatially selectively activating the set of photoreactive probes using light radiation and thereby inducing bonding between the set of labeled target probes and nearby molecules adjacent to the target biomolecule, washing out the unbound target probes, and further comprising the steps of labeling the labeled biomolecule / probe complex by labeling and selectively proximity labeling neighboring molecules adjacent to the target biomolecule.
[0251] Also disclosed herein is a mass spectrometry implementation method for processing a photolabeled sample to predict a biomarker. The method may include the step of separating a plurality of biological samples into a photolabeled sample group and an unlabeled sample group. The method may include the step of delivering a photoreactive kit as described herein to the photolabeled sample group and the unlabeled sample group. In some embodiments, the decoy molecule is non-covalently conjugated to a first molecule in the biological sample. The method may include the step of selectively illuminating a selected area of interest of the photolabeled sample group and keeping the unlabeled sample group in the dark, wherein the illuminating step allows the primary target probe to form a covalent bond with the sample. In some embodiments, the step of selectively illuminating the selected area of interest further includes the step of activating a photoreactive moiety in the selected area, thereby allowing the activated photoreactive moiety to allow the primary target probe to form a covalent bond with the biological sample in the selected area of interest. The method may include the step of removing an unconjugated photoreactive probe from the biological sample, thereby allowing the photoreactive probe to guide the selective illumination of the selected area of interest. In some embodiments, the activated photoreactive moiety can activate the primary target probe to have a free radical and form a covalent bond with an amino acid or biomolecule of a biological sample at a selected region of interest. In some embodiments, the amino acid can be alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, or valine.
[0252] The method may include the step of extracting a certain number of proteins bound by the target probe from the photo-labeled sample group and the non-labeled sample group by affinity precipitation between the proteins bound by the primary target probe and a certain number of affinity magnetic beads (e.g., streptavidin magnetic beads). The method may include the step of subjecting the extracted proteins to mass spectrometry analysis. The method may include the step of calculating the relative quantitative values of individual proteins in the identified protein list between the photo-labeled sample group and the non-labeled sample group based on the intensity values of the peptide fragments of the individual proteins. The method may include the step of determining a threshold value of the relative quantitative value between the photo-labeled sample group and the non-labeled sample group. The method may include the step of predicting at least one biomarker corresponding to the relative quantitative value of the individual proteins exceeding the threshold value after determining the threshold value.
[0253] Also disclosed herein are mass spectrometry implementation methods for processing a photolabeled sample to identify a list of biomarkers. The method may include the step of delivering a photoreactive kit as described herein to a biological sample. In some embodiments, the decoy molecule is non-covalently conjugated to a first molecule in the biological sample. The method may include the step of selectively illuminating a selected region of interest of the biological sample, thereby allowing the primary target probe to label proteins of the biological sample in the selected region of interest. In some embodiments, the step of selectively illuminating the selected region of interest further includes the step of activating the photoreactive moiety in the selected region, thereby allowing the activated photoreactive moiety to allow the primary target probe to form a covalent bond with the biological sample in the selected region of interest. The method may include the step of removing the unconjugated photoreactive probe from the biological sample, thereby allowing the photoreactive probe to guide selective illumination in the selected region of interest. In some embodiments, the activated photoreactive moiety can activate the primary target probe, thereby having a free radical and forming a covalent bond with an amino acid or biomolecule of the biological sample in the selected region of interest. In some embodiments, the amino acid can be alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, or valine.
[0254] The method may include the step of extracting a certain number of probe-labeled proteins from a biological sample by affinity precipitation between proteins bound by a primary target probe and a certain number of affinity magnetic beads (e.g., streptavidin magnetic beads). The method may include the step of subjecting the extracted proteins to mass spectrometry. The method may include the step of identifying the extracted proteins of the biological sample. The method may include the step of calculating the intensity value of the peptide fragments of each protein of the identified protein list of the biological sample. The method may include the step of sorting the identified protein list according to the intensity value of each protein.
[0255] The methods may include identifying and / or purifying one or more biomarkers (eg, adjacent or neighboring molecules).
[0256] The method for predicting a biomarker or identifying a list of biomarkers may further include the step of delivering a linker to a biological sample and conjugating the linker to a protein or biomolecule bound by the primary target probe through affinity between the linker and the primary target probe. In some embodiments, the linker may be a fluorescent linker to identify the location of the biological sample covalently bound to the primary target probe. The method may further include the step of delivering a tag-peroxidase to a biological sample and conjugating the tag-peroxidase to the linker to allow the tag-peroxidase to catalyze an attached target probe (e.g., a tyramide probe) to form a covalent bond between the attached target probe and the biological sample. In some embodiments, the tag-peroxidase activates the attached target probe to have a free radical and form a covalent bond between the attached target probe and the tyrosine of the biological sample.
[0257] Fig. 22 1. Illustration of a workflow using a photoreactive kit as described herein, followed by mass spectrometry analysis. A photoactivated kit coupled to a microscopic photolabeling system, followed by mass spectrometry analysis. Photolabeled nucleoli were harvested for LC-MS / MS analysis (lower left). Protein distribution of true positives of the nucleolar proteome. Proteins were sorted in order of ratio (two-photon labeling / control), with 97 of the top 100 proteins annotated as nucleolar proteins (middle of the lower figure). Gene Ontology analysis of the nucleolar proteome (lower right). Protocol: See [LC-MS / MS Analysis] and [Protein Identification and Label-Free Quantification] below.
[0258] [Example]
[0259] Experiment and Methods
[0260] [Conjugation of ruthenium-based antibodies] Ru(bpy) 3 NHS-ester (bis(2,2'-bipyridyl)-4'-methyl-4-carboxybipyridyl-ruthenium N-succinimidyl ester-bis(hexafluorophosphate) [CAS No.: 136724-73-7]) was conjugated with donkey anti-rabbit / donkey anti-mouse IgG antibody via amide coupling reaction, such as Figure 7 As shown in . 300 μg of antibody was mixed with Ru(bpy) 3 NHS-ester was prepared in 100 mM borate buffer (pH 8.0) at 0.5 mg / mL antibody and 0.35 mM Ru(bpy). 3 The reaction was carried out at room temperature in the dark for 2 h. Glycine was added to 100 mM to deactivate the reaction, and then the antibody-Ru(bpy) 3 The conjugate was purified using an offline gravity flow particle size analysis column (PD midiTrap G-25, Cytiva). Purified Antibody-Ru(bpy)3 The concentration of the conjugate was determined using the unconjugated antibody as a standard using Pierce TM BCA protein assay (Thermo Fisher Scientific) was used to measure Ru(bpy). 3 The molecules were conjugated to the antibodies and the purified products were further detected using NanoDrop spectrometer (Thermo Fisher Scientific) at 455 nm and 280 nm wavelengths.
[0261] [Cell preparation] The cells were cultured in Dulbecco's Modified Eagle Medium supplemented with 10% FBS at 37°C in a 5% CO2 humidified environment. 2×105 cells were seeded in a glass bottom chamber and incubated for about 16 hours to 80 to 90% cell coverage. The cells were then washed with PBS and fixed with 2.4% polyoxymethylene (PFA) or methanol. The fixed cells were incubated with PBS / 0.5% Triton X-100 to permeabilize the cell membrane, and blocked with PBS / 0.1% Triton X-100 with 3% BSA for 1 hour, followed by 0.002% streptavidin for 30 minutes and 40 μM biotin blocker for 15 minutes.
[0262] [Hybridization of Ru(bpy)-based Antibodies] The cells were incubated for 2 h at room temperature with the following primary antibodies in blocking buffer [PBS with 3% BSA / 0.1% Triton X-100]: rabbit anti-NCL, mouse anti-G3BP1, mouse anti-NPC. After washing with PBS / 0.1% Triton X-100, 10 μg / mL of antibody-Ru(bpy)-based Antibodies were added. 3 The conjugates were hybridized with primary antibodies overnight at 4° C. The cells were then stained with fluorescent markers (goat anti-rabbit AlexaFluor 647 or goat anti-mouse AlexaFluor 647) for 1 h at room temperature.
[0263] [Two-photon labeling at subcellular level for LC-MS / MS quantitative analysis] Cells were incubated with a two-photon (2P) labeling reagent containing 5 to 7 mM desthiobiotin-phenol and 0.005% methyl viologen. A two-photon laser coupled to a microscope system was used for spatially resolved photolabeling at a laser power of 100 to 200 mW, and the cells were subjected to a laser exposure time of 100 to 1000 microseconds. The labeled cells were washed with a buffer containing 10 mM sodium ascorbate, 5 mM trolox, and 0.02% sodium azide to quench the photochemical reaction, and the cells were finally washed three times with PBST.
[0264] [Verification of two-photon labeling performance by fluorescence microscopy] Labeled cells / signals were probed with neutravidin-DyLight 488 for 1 h in a blocking buffer containing 3% BSA / PBS / 0.1% Triton X-100, and the antibody-Ru(bpy) 3 The conjugates were hybridized with fluorescent markers (goat anti-donkey TexasRed) or anti-primary antibodies (goat anti-rabbit 568 or goat anti-mouse 568) for 1 h at room temperature. The cells were then stained with a nuclear marker (Hoechst 33258) for 30 min at room temperature. A Zeiss LSM 880 confocal microscope was used to verify that the labeling signal was within the organelle boundaries in xy and xz sections.
[0265] Figure 8 Results of Ab-Ru targeted photolabeling experiments are shown (confocal imaging of nucleolar markers (magenta), Ab-Ru (red), and signals labeled with 2P: desthiobiotin (green); scale bar: 20 μm). Figure 8 Results of Ab-Ru targeted photolabeling experiments are shown (confocal imaging of nucleolar markers (magenta), Ab-Ru (red), and signals labeled with 2P: desthiobiotin (green); scale bar: 20 μm).
[0266] [Protein extraction and enzyme digestion on magnetic beads] Labeled cells were scraped and harvested with a buffer containing 10 mM Tris (pH 8.0), 1% Triton X-100, 1x protease inhibitor cocktail, 10 mM sodium ascorbate, 5 mM Trolox, and 1 mM sodium azide. The harvested cells were sonicated for 2 min at 60% power with a Q 125 ultrasonic oscillator (Qsonica) at 1 s on / 2 s off intervals, followed by 2 h of scraping buffer evaporation using a SpeedVac system. 160 μL of a lysis buffer containing 4% sodium dodecyl sulfate (SDS), 1% Triton X-100, 100 mM Tris (pH 8.0), and 20 mM dithiothreitol (DTT) was added to the harvested cells, and the mixture was vortexed 5 times with 1 min on / 2 min off intervals. To recover the cross-linked amide groups from PFA fixation, the lysed cells were heated at 99°C for another 45 minutes, followed by another vortexing cycle of 1 min on / 2 min off for 5 times. The lysate was centrifuged at 16,000 g for 20 min at 20°C and the supernatant was collected. TMProtein concentration was measured by 660 nm protein assay (Thermo Fisher Scientific) and 240 μg of protein was immunoprecipitated. Streptavidin magnetic beads were washed three times with dilution buffer [0.5% Triton X-100 / PBS], the protein lysate was diluted 10-fold to reduce the SDS concentration below 0.4%, and the diluted lysate was added to the washed magnetic beads and incubated at 2 to 8° C. with rotation for 16 h. After this, the biotin-protein-bound magnetic beads were washed with the following washing buffers to minimize nonspecific binding: buffer A [2% SDS, 50 mM Tris (pH 8.0)]; buffer B [0.5 M NaCl, 0.1% deoxycholic acid, 0.1% SDS, 1% Triton X-100, 50 mM HEPES]; buffer C [0.5% deoxycholic acid, 0.5% Triton X-100, 10 mM Tris (pH 8.0), 250 mM LiCl]. The magnetic beads for enzyme digestion on the magnetic beads were further washed three times with 100 μL of 50 mM triethylammonium bicarbonate buffer, and then the biotin-protein-bound magnetic beads were mixed with 0.2 μg of trypsin / Lys-C (V5071, Promega) in a final volume of 20 μL at 37°C for 100 min for initial digestion. After this, the supernatant was collected and subjected to overnight enzymatic digestion without addition of other enzymes. Finally, the digestion product was acidified by adding 2 μL 10% formic acid and desalted with a C18 Ziptip. The desalted peptides were dried with a Speedvac and stored at -20°C before LC-MS / MS analysis.
[0267] [LC-MS / MS Analysis] Immunoprecipitated products were detected by data-dependent extraction mass spectrometry. LC-MS / MS analysis was performed using an UltiMate3000RSLCnano system (Thermo Fisher Scientific) coupled to an Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific). Desalted peptides were resuspended in water with 0.1% formic acid and loaded onto the PepMap TMPeptides were eluted on a 100C18 HPLC column (2 μm, 100 Å, 75 μm×25 cm; Thermo Fisher Scientific) with a 160-min gradient elution for nucleus-illuminated samples and a 120-min gradient elution for nucleolus- and SG-illuminated samples. Full MS spectra ranging from m / z 375 to 1500 were acquired in the Orbitrap at a resolution of 120,000, an AGC target of 4×105, and a maximum injection time of 50 ms. Fragment ion spectra were recorded in the Orbitrap at a resolution of 30,000 in the highest speed mode using a data-dependent method. Monoisotopic precursor ions were selected by using a quadrupole column with isolation windows of 1.2, 0.7, and 0.4 Th for ions with charge states of 2+, 3+, 4 to 7, respectively. All applied an AGC target of 4×105, a maximum injection time of 54 ms, high energy collision dissociation (HCD) fragmentation with a collision energy of 30%, and a maximum cycle time of 3 s. Dynamic exclusion was set to 60 s with an exclusion window of 10 ppm. Precursor ions with unassigned, 1+, or charge states above 8+ were excluded from fragmentation selection.
[0268] [Protein identification and label-free quantification] The raw data from the same batch of two-photon illumination were aligned to the UniProtKB / Swiss-Prot human protein database (version 2020.02, 20,365 entries) by the SequestHT algorithm with Proteome Discoverer (Thermo Fisher Scientific) for feature extraction, peptide identification, and protein inference. Database searches were performed as follows: up to three miscleaved tryptic peptides; a mass tolerance of 10 ppm for peptide ions and a mass tolerance of 0.05 Da for fragments; static carbamidomethylation on Cys residues (+57.0215 Da); dynamic deamidation on Asp and Gln residues (+0.9840 Da); oxidation on Met residues (15.9949 Da); acetylation on the protein N-terminus (+42.0106 Da); and dethiobiotinyl modification on Tyr residues (+331.1896). The minimum peptide length was set to 6 residues, and the false positive rate (FDR) for both peptides and proteins was set to 1%.
[0269] The time window for chromatographic peak alignment for label-free quantification was set to 20 min. Peptide level data were then normalized to total peptide intensity and the quantitative value for a given protein was derived from the sum of the normalized intensities of the top three intensely unique peptides belonging to that protein.
[0270] Fig. 9 Results of nucleolar labeling experiments are shown. Fig. 9 Shown are the total identified proteins from the nucleolar labeling experiment. 91% of the top 100 proteins are nucleolar proteins, indicating that labeling of the small ROI (nucleolus) with Ab-Ru and the target probe (biotin-phenol) is accurate and that the extraction step and identification of the tag (biotin) labeled proteins results in excellent labeling.
[0271] Proteins were ranked by their logarithmic fold change ratios of labeled cells versus unlabeled cells. Fig.10 The accuracy and power of proteomic composition disclosure for the discovery of novel proteins in stress granules (SGs) were demonstrated. 62% of the enriched proteins were SG proteins, and among the enriched proteins not included in the current SG database, at least 6 proteins were confirmed to colocalize with SGs by immunocytochemistry, indicating that antibody-based ruthenium-targeted photolabeling can discover novel proteins in the labeled regions.
[0272] Fig.11A Figures 1 to 3 show the structural formulations of three commercially available photoactivatable probes: Fig.11A :Ru(bpy) 3 2+ , Fig. 11B : Riboflavin and Fig. 11C : Rose Bengal (above). Photolabeling was performed on U-2OS cells with direct scanning of the full FOV (wavelength (λ) = 780 nm, power = 100 mW) with biotinyl tyramide. Fig.11D The highest fluorescence signal was obtained using Ru(bpy) 3 2+ Detection with 0.005% methyl viologen. Experimental protocol for Figure 11: U-2OS cells were cultured at room temperature with 500 μM desthiobiotin-phenol and 100 to 1000 μM range of free photoreactive moiety: Ru(bpy) 3 2+, riboflavin and Bengal rose red photolabeling reagents were incubated for 10 min. A two-photon microscope system was used for spatially resolved photochemical labeling with a full field of view (FOV). A two-photon microscope system was used for spatially resolved photolabeling with a laser power of 100 to 200 mW, and the cells were subjected to a laser exposure time of 100 to 200 microseconds. The labeled cells were washed with a buffer containing 10 mM sodium ascorbate, 5 mM trolox and 0.02% sodium azide to quench the photochemical reaction, and the cells were finally washed three times with PBST. The labeled cells were washed with a buffer containing 10 mM sodium ascorbate, 5 mM trolox and 0.02% sodium azide to quench the photochemical reaction, and the cells were finally washed three times with PBST. The labeled cells / signals were probed with neutravidin-DyLight 488 in a blocking buffer containing 3% BSA / PBS / 0.1% Triton X-100 for 1 h. The cells were then stained with a nuclear marker (Hoechst 33258) for 30 min at room temperature.
[0273] Fig.12 The photoreactive moiety was successfully conjugated to the antibody. 1 mg of the antibody was reacted with Ru(bpy)-NHS at a 100-fold molar ratio for 2 h or 24 h, and the product was detected by SEC-HPLC to verify the Ru(bpy) 3 2+ The conjugation of the molecule to the antibody. SEC-HPLC showed that Ru(bpy) 3 2+ The conjugated antibody (160 kDa) has two characteristic peaks at 280 nm and 455 nm at 10.4 min, indicating that Ru(bpy) 3 2+ Successfully conjugated with antibodies.
[0274] Figures 13A to 13B Results showing successful conjugation of the photoreactive moiety to the antibody. 10 mg of Ru(bpy) 3 2+ Antibody conjugation followed by removal of unconjugated Ru(bpy) using a 40 kDa Zeba spin desalting column 3 2+ The two absorbances at 280nm and 455nm were observed to be mostly Ru(bpy) 3 2+ Conjugated antibody peak. No free Ru(bpy) was found at 455nm absorbance within 16 minutes. 3 2+ .about Fig.12 and 13AExperimental procedures to 13B: See 1) "[Conjugation of ruthenium-based antibodies]" (above), and 2) "[SEC-HPLC experimental procedure (to verify Ab-Ru conjugates)". The purity of unconjugated antibodies and Ru(bpy)-conjugated antibodies (Ab-Ru) in their native state was determined by SEC-HPLC. The mobile phase was sodium phosphate buffer, pH 7.4. The test sample was diluted to 1 mg / mL with the mobile phase, and 100 μL of the resultant was injected into a TSKgelG3000SWXL column, 7.8 mm The protein separation was performed in a HPLC system with an ID×30 cm. The mobile phase was applied at an isocratic flow rate of 1.0 mL / min for protein separation. The characteristics of the eluted products to be monitored were unconjugated antibody (160 kDa), Ab-Ru (160 kDa), aggregates (>160 kDa) and free Ru(bpy) molecules (628 Da). Unconjugated antibody and aggregates were detected at 280 nm, Ab-Ru and free Ru(bpy) molecules were detected at 455 nm. All measurements were performed with a photodiode array detector.
[0275] Figures 14A to 14C Results of specific photolabeling of induced cells using ruthenium-based photoreactive moieties conjugated to antibodies are shown. Figure 14 shows experimental results of photolabeling via antibody-based ruthenium (Ab-Ru) targeting (confocal imaging of stress granule markers (green), photolabeled signal: desthiobiotin (red); scale bar: 10 μm). Fig.14A Shown is illumination at 470 nm. Fig. 14B A control group (no light) is shown. Fig. 14C show Fig.14A Z-axis of the cell shown in (side view). Antibody-conjugated Ru(bpy) 3 2+ (Ab-Ru) produces specific and high-resolution results after illumination. U-2OS cells were induced with arsenite and hybridized with rabbit anti-G3BP1 (stress granule marker: green) to show the region of interest for labeling. Donkey-mouse secondary antibody was hybridized with Ru(bpy) 3 2+Conjugated (Ab-Ru photoactivatable probe) and illuminated with desthiobiotin-phenol and methyl viologen at 470 nm LED wavelength. Clear stress granule patterns were observed after Dy-550 neutravidin staining. The control group without light showed no stress granule patterns after Dy-550 neutravidin staining. Z-axis images also show the specificity and high resolution of the photolabeling effect in the z plane using the Ab-Ru photoactivatable probe. Experimental procedures for Figures 14, 17, 18, 20, 22, 23 and 24: "Hybridization of ruthenium-based antibodies" (see above), then see "Labeling and Analysis": Cells were incubated with a photolabeling reagent containing 5 mM desthiobiotin-phenol and 0.005% methyl viologen. A 470 nm LED laser coupled to a microscope system was used for spatially resolved photolabeling with a laser power of 100 to 200 mW, and the cells were subjected to laser exposure times of 37 to 1000 microseconds. The labeled cells were washed with a buffer containing 10 mM sodium ascorbate, 5 mM trolox and 0.02% sodium azide to quench the photochemical reaction, and the cells were finally washed three times with PBST.
[0276] Labeled cells / signals were probed with neutravidin-DyLight 488 in blocking buffer containing 3% BSA / PBS / 0.1% Triton X-100 for 1 h, and mouse anti-G3BP1 antibody was hybridized with a fluorescent marker (goat anti-mouse 488) for 1 h at room temperature. A Zeiss LSM 880 confocal microscope was used to verify that the labeling signal was within the organelle boundaries in xy and xz sections.
[0277] FIG. 14 shows the experimental results of antibody-based ruthenium (Ab-Ru) targeted photolabeling (confocal imaging of stress granule markers (green), photolabeled signal: desthiobiotin (red); scale bar: 10 μm).
[0278] Fig.15 Selective photolabeling of mouse brain tissue samples using a probe with a ruthenium-based photoreactive moiety and an antibody is shown. The control group (no light) shows no labeling. 20 μM frozen mouse brain tissue sections were stained with rabbit anti-nucleolin (a nuclear marker) followed by anti-rabbit Ab-Ru photoactivatable probe (donkey anti-rabbit secondary antibody with Ru(bpy) 3 2+ Conjugated) and illuminated with desthiobiotin-phenol and methyl viologen at 457nm LED wavelength with power of 10, 20, 30, 40, 50, 60mW. Clear nuclear pattern was observed after Dy-550 neutravidin staining to show the light labeling signal (dethiobiotin) on the selected area of the tissue. The control area without light showed no labeling signal. About Fig.15 ,16 Experimental procedures for tissue preparation, primary antibody and Ab-Ru staining of and 19: "Tissue preparation, primary antibody and Ab-Ru staining". PFA-fixed mouse brain tissue was embedded in optimal cutting temperature (OCT) compound and cryosectioned onto coverslips. 10 to 30 μm mouse brain sections were incubated overnight at 4°C with rabbit anti-NCL antibody in blocking buffer [PBS / 0.1% Triton X-100 with 3% BSA]. After washing with PBS / 0.1% Triton X-100, 10 μg / mL of antibody-Ru (bpy) was added. 3 The conjugate was hybridized with the primary antibody overnight at 4°C. The tissue sections were then stained with fluorescent goat anti-rabbit AlexaFluor 647 for 1 hour at room temperature. Fig.15 and 16 Additional experimental procedure: "457LED light source": 10 to 30μm tissue sections were incubated with a labeling reagent containing 5mM desthiobiotin-phenol and 0.005% methyl viologen. A 457nm LED laser coupled to the microscope system was used for spatially resolved photolabeling with a laser power of 100 to 200mW, and the tissue sections were subjected to a laser exposure time of 37 to 1000 microseconds. The labeled tissue sections were washed with a buffer containing 10mM sodium ascorbate, 5mMtrolox and 0.02% sodium azide to quench the photochemical reaction, and then finally washed three times with PB ST. About Fig.15 , 16 Additional experimental procedures for 19: "Verification of optical labeling performance": The labeled tissue / signal was probed with Neutravidin-DyLight 550 for 1 h in blocking buffer containing 3% BSA / PB S / 0.1% Triton X-100. Tissue sections were then stained with a nuclear marker (DAPI) for 30 min at room temperature. Fluorescence microscopy or Zeiss LSM 880 confocal microscopy was used to verify that the labeling signal was within the nuclear borders in xy and xz sections.
[0279] Fig.16 Results of an experiment are shown showing photolabeling of mouse brain tissue samples using a probe with a ruthenium-based photoreactive moiety and an antibody and neutravidin staining. 20 μM frozen mouse brain tissue sections were stained with rabbit anti-nucleolin (a nuclear marker) followed by an anti-rabbit Ab-Ru photoactivatable probe (donkey anti-rabbit secondary antibody was conjugated to Ru(bpy) 3 2+ Conjugated) and illuminated with desthiobiotin-phenol and methyl viologen at 457nm LED wavelength. Clear nuclear pattern was observed after Dy-550 neutravidin staining. Z-axis image shows the use of antibody-Ru(bpy)3 2+ Specificity and high resolution of photolabeling effects of photoactivatable probes in the z plane.
[0280] Fig.17 Results of an experiment are shown, which shows the detection of nucleolar regions using a probe with a ruthenium-based photoreactive moiety and a secondary antibody bait. The photolabeled signal was labeled using a two-photon technique. The photolabeled (on) and unlabeled (off) regions of interest were probed with an Ab-Ru photoactivatable probe (donkey anti-rabbit secondary antibody and Ru(bpy) 3 2+ Conjugated) localized in the nucleolus (rabbit anti-NCL antibody: red). The photolabeled (PL) signal was stained with anti-desthiobiotin (Dy-488 Neutravidin). The PL signal was labeled using two-photon at wavelength = 780 nm. Fig.17 , 18, 20, 22, 23, 24 experimental procedures: 1). [Two-photon labeling at the subcellular level for LC-MS / MS quantitative analysis] (see above), and 2) [Verification of the performance of two-photon labeling by fluorescence microscopy] (see above).
[0281] Figures 18A to 18C Results of experiments showing detection of photolabeled subcellular compartments using probes with ruthenium-based photoreactive moieties and Alexa fluor 568 secondary antibody baits bound to primary antibodies are shown. Fig.18A Nucleolar detection using rabbit anti-nucleolin antibody is shown. Fig.18B Results of an experiment showing nuclear pore complex detection using mouse anti-NPC antibody are shown. Fig.18C Stress granule detection using mouse anti-Ras GTPase-activating protein-binding protein 1 antibody is shown.
[0282] Fig.19 Results of experiments are presented, which show specific two-photon labeling in fixed mouse brain tissue. Fig.19 Experimental procedure "2p labeling": 10-30 μm mouse brain tissue sections were incubated with a two-photon (2P) labeling reagent containing 5-7 mM desthiobiotin-phenol and 0.005% methyl viologen. A two-photon laser coupled to a microscope system was used for spatially resolved photolabeling with a laser power of 10-200 mW, and the tissue sections were subjected to a laser exposure time of 10-1000 microseconds. The labeled tissue sections were washed with a buffer containing 10 mM sodium ascorbate, 5 mM trolox, and 0.02% sodium azide to quench the photochemical reaction, and the tissue sections were finally washed three times with PBST.
[0283] Fig. 20Results of experiments showing photolabeling of stress granules using horseradish peroxidase-activated desthiobiotin covalently bound to tyrosine residues at and adjacent to the enzyme site are shown. Fig. 20 and 21 Experimental procedure: "Proximity labeling after photolabeling": Labeled cells / tissues / signals are probed with Neutravidin-DyLight488 or Neutravidin-DyLight550 in blocking buffer containing 3% BSA / PBS / 0.1% TritonX-100 at room temperature for 1 to 2 hours, followed by hybridization with Neutravidin-HRP (biotin-HRP) for 1 hour at room temperature. 100 μM desthiobiotin is added and incubated in the cell / tissue sample for 30 minutes at room temperature. Hydrogen peroxide is added to catalyze the covalent binding of HRP-activated desthiobiotin to tyrosine residues at and adjacent to the enzyme site. Proximity labeled signals are probed with Neutravidin-DyLight550 in blocking buffer containing 3% BSA / PBS / 0.1% Triton X-100 for 1 hour at room temperature. Fluorescence microscopy or Zeiss LSM 880 confocal microscopy was used to verify that the labeling signal was within the organelle boundaries in xy and xz sections.
[0284] Fig.21 Photolabeled mouse liver tissue samples are shown using proximity labeling with horseradish peroxidase-activated desthiobiotin covalently bound to tyrosine residues at and adjacent to the enzyme site.
[0285] Fig. 22 Shown is an example of a workflow using a photoactivation kit coupled to a microscopic photolabeling system followed by mass spectrometry analysis as described herein.
[0286] Fig.23 Experimental results are shown showing confocal micrographs depicting precise and accurate photolabeling of (PL) stress granules with antibody-ruthenium photoactivatable probes using a two-photon labeling system at wavelength = 780 nm.
[0287] Figures 24A to 24C Two-photon labeling using an antibody-ruthenium photoactivatable probe is shown. Fig.24A Fann diagram showing three biological replicates of two-photon labeling of the Ab-Ru photoactivatable probe. Fig. 24B The relative protein levels (ratio of PL / CTL) in the photolabeled samples and the control samples are shown in log 2 Volcano plot of dimensionality. Overrepresented (enriched) proteins are shown in the upper right bounded by arrows a and b. Fig.24CIt shows that a true positive rate of 74% (annotated as stress granules (sg)) was found in the top 50 proteins ranked by the PL / CTL ratio. Experimental procedures: See [LC-MS / MS analysis] and [Protein identification and label-free quantification] above.
[0288] Figures 25A to 25B 37 of the top 50 proteins ranked by PL / CTL ratio are annotated as stress granule proteins (upper panel). Potential stress granule proteins were validated by immunofluorescence detection. Confocal micrographs depict stress granule formation in U-2OS cells with or without arsenite stress stimulation of potential stress granule proteins. Potential stress granule proteins (green) are highly colocalized with the well-known G3BP 1S G marker (red). Proteomic composition reveals the accuracy and power of this method to discover novel stress granule biomarkers (lower panel). Lens: 63x oil.
[0289] When a feature or element is referred to herein as being "on" another feature or element, it may be directly on the other feature or element or there may be the presence of intervening features and / or elements. Conversely, when a feature or element is referred to as being "directly on" another feature or element, there are no intervening features or elements. It should also be understood that when a feature or element is referred to as being "connected," "attached," or "coupled" to another feature or element, it may be directly connected, attached, or coupled to the other feature or element or there may be the presence of intervening features or elements. Conversely, when a feature or element is referred to as being "directly connected," "directly attached," or "directly coupled" to another feature or element, there are no intervening features or elements. Although described or shown with respect to one embodiment, the features and elements so described or shown may be applicable to other embodiments. Those skilled in the art will appreciate that structures or features referred to as being configured "adjacent" another feature may have portions that overlap or are located below the adjacent feature.
[0290] The terms used herein are only for the purpose of describing specific implementations and are not intended to limit the present invention. For example, the singular forms "a", "and", and "the" as used herein are also intended to include the plural forms, unless the context clearly indicates otherwise. It should be further understood that when this specification uses the term "comprises and / or comprising", it explicitly describes the presence of the features, steps, operations, elements and / or components described, but does not exclude the presence or addition of one or more other features, steps, operations, elements, components and / or their groups. The term "and / or" as used herein includes any and all combinations of one or more of the related listed items and can be abbreviated as " / ".
[0291] For ease of explanation, spatially relative terms such as "under," "below," "lower," "over," "upper," and the like may be used herein to describe the relationship of one element or feature to another element or feature as illustrated in the figures. It should be understood that in addition to the orientations described in the figures, spatially relative terms are also intended to cover different orientations of the device in use or operation. For example, if the device in the figure is inverted, the elements described as "under or beneath" other elements or features will be oriented "over" the other elements or features. Thus, the exemplary term "under" may cover both "over" and "under" orientations. The device may be oriented in other ways (rotated 90 degrees or other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms "upward," "downward," "vertical," "horizontal," and the like are used for explanation purposes only unless otherwise specifically indicated.
[0292] Although the terms "first" and "second" may be used herein to describe various features / elements (including steps), such features / elements should not be limited by such terms unless the context indicates otherwise. Such terms may be used to distinguish one feature / element from another feature / element. Therefore, without departing from the guidance of the present invention, the first feature / element discussed below can also be referred to as the second feature / element, and similarly, the second feature / element discussed below can also be referred to as the first feature / element.
[0293] Throughout this specification and the claims that follow, unless the context requires otherwise, the word "comprise" and variations (such as "comprises and comprising") mean that various components can be used together in methods and articles (e.g., components and devices including apparatus and methods). For example, it should be understood that the term "comprising" implies the inclusion of any stated elements or steps but does not exclude any other elements or steps.
[0294] It should generally be understood that any of the devices and methods described herein are inclusive, but all or a subset of components and / or steps may alternatively be exclusive and may be expressed as "consisting of" or alternatively "consisting essentially of" various components, steps, subcomponents or sub-steps.
[0295] As used in the specification and claims herein (including as used in the examples) and unless otherwise expressly specified, all numbers may be read as if beginning with the word "about or approximately", even if the term does not appear explicitly. When describing size and / or position, the idiom "about or approximately" may be used to indicate that the value and / or position described is within a reasonable expected range of value and / or position. For example, a numerical value may have a value of + / -0.1% of the value (or range of values), + / -1% of the value (or range of values), + / -2% of the value (or range of values), + / -5% of the value (or range of values), + / -10% of the value (or range of values), etc. It should also be understood that any numerical value given herein includes about (about or approximately) the value, unless the context indicates otherwise. For example, if the value "10" is disclosed, "about 10" is also disclosed. It is intended that any numerical value listed herein includes all sub-ranges included therein. It is also understood that when a value is disclosed, "less than or equal to the value," "greater than or equal to the value," and possible ranges between values are also disclosed, as appropriately understood by one skilled in the art. For example, if a value "X" is disclosed, "less than or equal to X" and "greater than or equal to X" (e.g., where X is a numerical value) are also disclosed. It is also understood that throughout the application, data is provided in a number of different formats, and that such data represent endpoints and starting points and ranges for any combination of data points. For example, if a specific data point "10" and a specific data point "15" are disclosed, it is understood that greater than, greater than or equal to, less than, less than or equal to, and equal to 10 and 15, as well as between 10 and 15 are disclosed. It is also understood that each unit between two specific units is also disclosed. For example, if 10 and 15 are disclosed, 11, 12, 13, and 14 are also disclosed.
[0296] Any of the methods described herein (including user interfaces) may be implemented as software, hardware, or firmware, and may be described as a non-transitory computer-readable storage medium (e.g., a computer, tablet, smartphone, etc.) storing a set of instructions that can be executed by a processor. When executed by the processor, the processor controls the execution of any of the steps, including but not limited to: display, communication with the user, analysis, modification of parameters (including timing, frequency, intensity, etc.), measurement, alarm, or the like.
Claims
1. A photoreactive kit comprising: The photoreactive probe represented by formula (I): GCB (I) in The C part is a single chemical bond or linker; The B part includes 1 to 50 photoreactive moieties and is combined with the C part, wherein each of the 1 to 50 photoreactive moieties is derived from a ruthenium-based compound represented by formula (II): Wherein in formula (II): L 1 , L 2 , L 3 and L 4 Each is independently a ligand; and X 1 and X 2 each independently a ligand having a reactive moiety, wherein the reactive moiety is configured to be bonded to the C moiety; The G portion comprises a bait molecule bound to the C portion, wherein the bait molecule is an antibody and is configured to be conjugated to a first molecule in the sample; and a primary target probe comprising a detectable label moiety bound to a photoexcitable target moiety, Wherein when the photoreactive probe is photoactivated with a two-photon light source in the wavelength range of 700nm to 1100nm or with a single light source in the wavelength range of 200nm to 1100nm and the primary target probe is acted upon by the photoactivated probe to form a photoexcited primary target probe, the photoexcited primary target probe is configured to form a covalent bond with a target molecule in the sample.
2. The photoreactive kit according to claim 1, wherein X 1 and X 2 Each is independently selected from the group consisting of: 3-ethynylpyridine, 3-(bromomethyl)pyridine, maleimide, 4'-methyl-4-carboxybipyridyl-N-succinimide ester, nicotinaldehyde, 1-(4-(pyridin-3-yl)-1H-1,2,3-triazol-1-yl)ethanone, 4-pentynenitrile and 4-aminobutyne.
3. The photoreactive kit according to claim 1, wherein L 1 With L 2 to form a first bidentate ligand and L 3 With L 4 The first bidentate ligand and the second bidentate ligand are independently selected from the group consisting of: 2,2'-bipyridyl (bpy), 4,4'-dicyano-5,5'-dimethyl-2,2'-bipyridyl (CN-Me-bpy), 4,4'-dimethyl-2,2'-bipyridyl (dmb), 4,4'-di-tert-butyl-2,2'-bipyridyl (dbpy), 4,4',5,5'-tetramethyl-2,2 '-Bipyridine (tmb), 2-phenylpyridine (ppy), 6-bromo-2,2'-bipyridine, 6,6'-dibromo-2,2'-bipyridine, 5-bromo-2,2'-bipyridine, 6-amino-2,2'-bipyridine, 6,6'-diamino-2,2'-bipyridine, 2,2'-bipyridine-6-carbonitrile, 2,2'-bipyridine-6,6'-bis(carbonitrile), 2,2'-bipyridine-6-carboxylic acid, 2,2'-bipyridine-6,6'-dicarboxylic acid and bisquinoline.
4. The photoreactive kit according to claim 1, wherein the ruthenium-based compound represented by formula (II) is one of the following: and its derivatives.
5. The photoreactive kit of claim 1, wherein the photoreactive portion comprises the following: or its derivatives.
6. The photoreactive kit according to any one of claims 1 to 5, wherein the linker comprises the following parts:
7. The photoreactive kit according to any one of claims 1 to 6, wherein the linker comprises amino acids, (PEG) n , oligonucleotide or peptide, wherein n is an integer from 1 to 20.
8. The photoreactive kit of claim 1 , wherein when the photoreactive probe is photoactivated with a two-photon light source in the wavelength range of 700 nm to 1100 nm and the primary target probe is acted upon by the photoactivated probe to form a photoexcited primary target probe, the photoexcited primary target probe is configured to form a covalent bond with a target molecule in the sample.
9. The photoreactive kit of claim 1 , further wherein when the photoreactive probes are photoactivated with a single light source in the wavelength range of 300 nm to 800 nm and the primary target probes act upon by the photoactivated probes to form photoexcited primary target probes, the photoexcited primary target probes are configured to form covalent bonds with target molecules in the sample.
10. The photoreactive kit according to any one of claims 1 to 6, wherein the detectable label portion is at least one of a biotin derivative, a digoxigenin tag, a CLIP-tag, a halogen tag, a SNAP-tag, an oligonucleotide, a peptide tag, and a click chemistry tag, and the click chemistry tag comprises an alkyne-based portion or an azide-based portion.
11. The photoreactive kit of any one of claims 1 to 6, wherein the photoexcitable target moiety is at least one of: (R'=CH 2 CH 2 OMe or Et), (X=N 2 + or Br), and its derivatives.
12. The photoreactive kit according to any one of claims 1 to 6, wherein the primary target probe is desthiobiotin-phenol or biotin-phenol.
13. The photoreactive kit according to any one of claims 1 to 6, wherein the photoexcitable target moiety is 14. The photoreactive kit of claim 13, wherein the detectable tag moiety is at least one of a biotin derivative, a click chemistry tag, a CLIP-tag, a digoxigenin tag, a halogen tag, an oligonucleotide, a peptide tag, and a SNAP-tag, and the photoreactive moiety comprises a moiety of the formula:
15. The photoreactive kit of any one of claims 1 to 6, further comprising a linker, wherein the linker is conjugated to the detectable label portion of the primary target probe.
16. The photoreactive kit of claim 15, wherein the linker is a fluorescent linker.
17. The photoreactive kit of claim 15, further comprising a tag-enzyme complex, wherein the tag-enzyme complex is conjugated to the linker, and further wherein the enzyme of the tag-enzyme complex comprises a peroxidase.
18. The photoreactive kit according to any one of claims 1 to 6, further comprising: a linker, wherein the linker is conjugated to the detectable tag portion of the primary target probe; a tag-enzyme complex, wherein the tag of the tag-enzyme complex is conjugated to the linker, and further wherein the enzyme of the tag-enzyme complex comprises a peroxidase; and The attached target probe is configured to covalently bond with the target molecule through the catalytic activity of the peroxidase of the tag-enzyme complex to form the attached target probe.
19. The photoreactive kit of claim 18, wherein the additional targeting probe is the same as or different from the primary targeting probe and comprises an additional targeting probe tag portion and an additional targeting probe target portion.
20. The photoreactive kit of claim 18, wherein the linker is a fluorescent linker.
21. The photoreactive kit of any one of claims 1 to 6, wherein the concentration of the photoreactive probe ranges from 0.1 μg / mL to 100 μg / mL and the concentration of the primary target probe ranges from 1 μM to 20 mM.
22. A photoreactive kit comprising: The photoreactive probe represented by formula (I): GCB (I) in The C part is a single chemical bond or linker; The B portion includes at least one photoreactive portion bound to the C portion; and The G portion comprises a decoy molecule bound to the C portion; and a primary target probe comprising a detectable label moiety bound to a photoexcitable target moiety, wherein the decoy molecule of the photoreactive probe is configured to be conjugated to a first molecule in a sample, and wherein when the photoreactive probe is photoactivated and the primary target probe is acted upon by the photoactivated probe to form a photoexcited primary target probe, the photoexcited primary target probe is configured to form a covalent bond with a target molecule in the sample.
23. The photoreactive kit of claim 22, wherein the bait molecule comprises at least one of the following: an antibody, avidin, neutravidin, streptavidin, another biotin-binding protein, a CLIP-tag, a halo-tag, a SNAP-tag, another self-labeled protein tag, a DNA or RNA fluorescent in situ hybridization (FISH) probe, another RNA molecule, another nucleic acid molecule, protein A, protein G, protein L, protein A / G, protein A / G / L, another immunoglobulin binding peptide, a drug, or another small molecule.
24. The photoreactive kit of claim 22, wherein the photoreactive moiety is at least one of riboflavin, luciferin, another flavin derivative, luciferin or a derivative thereof, methylene blue or a derivative thereof, miniSOG photosensitive protein, Killer Red photosensitive protein, another photosensitive protein, pterin or a derivative thereof, a ruthenium-based photocatalyst, and Rose Bengal or a derivative thereof.
25. The photoreactive kit of claim 22, wherein the decoy molecule is an antibody and a certain number of the photoreactive moieties are bound to the antibody via the C moiety, wherein the number ranges from 1 to 50.
26. The photoreactive kit of claim 22, wherein the photoreactive moiety is configured to allow the primary target probe to form a covalent bond with a molecule of the sample.
27. The photoreactive kit of claim 25, wherein the photoreactive moiety is derived from a ruthenium-based compound represented by formula (II): Wherein in formula (II): L 1 , L 2 , L 3 and L 4 Each is independently a ligand; and X 1 and X 2 Each is independently a ligand, wherein X 1 and X 2 At least one of the photoreactive probes has a binding region, wherein the at least one binding region binds to the C portion of the photoreactive probe.
28. The photoreactive kit of claim 27, wherein X 1 and X 2 Each is independently selected from the group consisting of: 3-ethynylpyridine, 3-(bromomethyl)pyridine, maleimide, 4'-methyl-4-carboxybipyridyl-N-succinimide ester, nicotinaldehyde, 1-(4-(pyridin-3-yl)-1H-1,2,3-triazol-1-yl)ethanone, 4-pentynenitrile and 4-aminobutyne.
29. The photoreactive kit of claim 27, wherein L 1 With L 2 to form a first bidentate ligand and L 3 With L 4 The first bidentate ligand and the second bidentate ligand are independently selected from the group consisting of: 2,2'-bipyridyl (bpy), 4,4'-dicyano-5,5'-dimethyl-2,2'-bipyridyl (CN-Me-bpy), 4,4'-dimethyl-2,2'-bipyridyl (dmb), 4,4'-di-tert-butyl-2,2'-bipyridyl (dbpy), 4,4',5,5'-tetramethyl-2,2 '-Bipyridine (tmb), 2-phenylpyridine (ppy), 6-bromo-2,2'-bipyridine, 6,6'-dibromo-2,2'-bipyridine, 5-bromo-2,2'-bipyridine, 6-amino-2,2'-bipyridine, 6,6'-diamino-2,2'-bipyridine, 2,2'-bipyridine-6-carbonitrile, 2,2'-bipyridine-6,6'-bis(carbonitrile), 2,2'-bipyridine-6-carboxylic acid, 2,2'-bipyridine-6,6'-dicarboxylic acid and bisquinoline.
30. The photoreactive kit according to claim 27, wherein the ruthenium-based compound represented by formula (II) is any one of the following: and its derivatives.
31. The photoreactive kit of claim 22, wherein the photoreactive portion comprises the following: or its derivatives.
32. The photoreactive kit of claim 22, wherein the linker comprises the following:
33. The photoreactive kit of claim 22, wherein the linker comprises amino acids, (PEG) n , oligonucleotide or peptide, wherein n is an integer from 1 to 20.
34. The photoreactive kit of claim 22, wherein the photoreactive moiety is activated with a light source in the wavelength range of 200 nm to 1100 nm to allow the primary target probe to form a covalent bond with the target molecule in the sample.
35. The photoreactive kit of claim 22, wherein the photoreactive moiety is activated with a two-photon light source within a wavelength range of 700 nm to 1100 nm to allow the primary target probe to form a covalent bond with the target molecule in the sample.
36. The photoreactive kit of claim 27, wherein the photoreactive moiety is activated with a light source within a wavelength range of 300 nm to 800 nm to allow the primary target probe to form a covalent bond with the target molecule in the sample.
37. The photoreactive kit of claim 27, wherein the photoreactive moiety is activated with a two-photon light source within a wavelength range of 700 nm to 1100 nm to allow the primary target probe to form a covalent bond with the target molecule in the sample.
38. The photoreactive kit of claim 22, wherein the detectable tag moiety is at least one of a biotin derivative, a CLIP-tag, a digoxigenin tag, a halogen tag, an oligonucleotide, a peptide tag, a SNAP-tag, and a click chemistry tag, and the click chemistry tag comprises an alkyne-based moiety or an azide-based moiety.
39. The photoreactive kit of claim 22, wherein the target moiety is one or more of: (R'=CH 2 CH 2 OMe or Et), (X=N 2 + or Br), and its derivatives.
40. The photoreactive kit of claim 22, wherein the primary target probe is desthiobiotin-phenol or biotin-phenol.
41. The photoreactive kit of claim 27, wherein the photoexcitable target moiety is 42. The photoreactive kit of claim 41, wherein the detectable tag moiety is at least one of a biotin derivative, a click chemistry tag, a CLIP-tag, a digoxigenin tag, a halogen tag, an oligonucleotide, a peptide tag, and a SNAP-tag, and the photoreactive moiety comprises a moiety of the formula:
43. The photoreactive kit of any one of claims 22 to 42, further comprising a linker, wherein the linker is conjugated to the detectable label portion of the primary target probe.
44. The photoreactive kit of claim 43, wherein the linker is a fluorescent linker.
45. The photoreactive kit of claim 43, further comprising a tag-enzyme complex, wherein the tag-enzyme complex is conjugated to the linker, and further wherein the enzyme of the tag-enzyme complex comprises a peroxidase.
46. The photoreactive kit according to any one of claims 37 to 42, further comprising: a linker, wherein the linker is conjugated to the detectable tag portion of the primary target probe; a tag-enzyme complex, wherein the tag of the tag-enzyme complex is conjugated to the linker, and further wherein the enzyme of the tag-enzyme complex comprises a peroxidase; and The attached target probe is configured to covalently bond with the target molecule through the catalytic activity of the peroxidase of the tag-enzyme complex to form the attached target probe.
47. The photoreactive kit of claim 46, wherein the additional target probe is different from the primary target probe and comprises an additional target probe tag portion and an additional target probe target portion.
48. The photoreactive kit of claim 46, wherein the linker is a fluorescent linker.
49. The photoreactive kit of claim 22, wherein the concentration of the photoreactive probe ranges from 0.1 μg / mL to 100 μg / mL and the concentration of the primary target probe ranges from 1 μM to 20 mM.
50. A method for photoreactive labeling, the method comprising: delivering a number of photoreactive probes of the photoreactive kit of any one of claims 22 to 33 and 40 to 42 to a sample; non-covalently conjugating the decoy molecule of the first portion of the photoreactive probe to a certain number of first molecules in the sample; delivering a number of primary target probes of the photoreactive kit of any one of claims 22 to 33 and 40 to 42 to the sample; selectively illuminating a selected region of interest of the sample with optical radiation to activate the photoreactive moieties of a number of photoreactive probes to form a number of photoactivated photoreactive probes in the selected region; photoexciting the photoexcitable target portion of the primary target probe with a number of photoactivated photoreactive probes to form a number of photoexcited primary target probes having photoexcited target portions; and Covalent bonds are formed between a number of the photoexcited primary target probes and a number of target molecules in the selected region of interest in the sample, thereby binding a number of the primary target probes to a number of the target molecules.
51. The method according to claim 50, wherein the decoy molecules of the first portion of the photoreactive probe are non-covalently conjugated with a certain number of first molecules in the sample to leave the second portion of the photoreactive probe unconjugated, the method further comprising the following steps: The unconjugated photoreactive probe is removed from the sample.
52. The method according to claim 50, further comprising the steps of: delivering a quantity of linkers to the sample; and A certain number of said linkers are conjugated to a certain number of said detectable label moieties of said primary target probes.
53. The method of claim 52, wherein a certain number of said linkers comprise fluorescent linkers, said method further comprising the steps of: The positions of a certain number of the fluorescent linkers in the sample are detected, and thereby the positions of a certain number of the primary target probes and a certain number of the target molecules covalently bound thereto are identified.
54. A method according to claim 50, wherein the step of photoexcitation further comprises photoexciting the primary target probe to form a certain number of photoexcited primary target probes each having a free radical, and wherein the step of forming a covalent bond comprises forming a covalent bond between each of the certain number of the photoexcited primary target probes and an amino acid in each of the certain number of the target molecules in the selected region of interest in the sample.
55. The method of claim 50, wherein the step of forming a covalent bond comprises forming a covalent bond between each of a certain number of the photoexcited primary target probes and an amino acid in each of a certain number of the target molecules in the selected region of interest in the sample.
56. The method of claim 54 or 55, wherein the amino acid is selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine.
57. The method according to claim 52 or 53, further comprising the steps of: delivering the linker of the photoreactive kit of claim 46 or 47 to the sample, wherein the linker is conjugated to the detectable label portion of the primary target probe; delivering the tag-peroxidase complex of the photoreactive kit of claim 46 or 47 to the sample, wherein the tag of the tag-enzyme complex is conjugated to the linker, and further wherein the enzyme of the tag-enzyme complex comprises a peroxidase; delivering an additional target probe of the photoreactive kit of claim 46 or 47 to the sample, wherein the additional target probe is configured to form a covalent bond with the target molecule via the catalytic activity of the peroxidase of the tag-enzyme complex; and The tag-peroxidase complex is conjugated to the linker, wherein the tag-peroxidase catalyzes the appended target probe to form a covalent bond between the appended target probe and the sample.
58. The method according to claim 57, wherein the tag-peroxidase complex activates the additional target probe to have a free radical at the target portion of the additional target probe and forms a covalent bond between the target portion of the additional target probe and tyrosine of the sample.
59. An analytical method, comprising: delivering a number of photoreactive probes of the photoreactive kit of any one of claims 22 to 33 and 40 to 42 to the sample; non-covalently conjugating the decoy molecule of the first portion of the photoreactive probe to a certain number of first molecules in the sample; delivering a number of primary target probes of the photoreactive kit of any one of claims 22 to 33 and 40 to 42 to the sample; and illuminating the sample from an imaging light source of an image guidance system; imaging the illuminated sample with a camera; Acquire at least one subcellular morphology image of the sample in a first field of view with a camera; processing the at least one image and determining a region of interest in the sample based on the processed image; Obtaining coordinate information of the area of interest; and The region of interest is selectively illuminated by optical radiation to activate the photoreactive moiety based on the coordinate information, wherein the activated photoreactive moiety allows the primary target probe to form a covalent bond with the sample at the region of interest.
60. The method of claim 59, wherein the step of selectively illuminating comprises illuminating an area at 10 μs / pixel to 200 μs / pixel, 25 μs / pixel to 400 μs / pixel, 50 μs / pixel to 300 μs / pixel, 75 μs / pixel to 200 μs / pixel, or 400 μs / pixel to 5000 μs / pixel.
61. The method of claim 59, wherein the step of selectively illuminating comprises illuminating at a power intensity of 1 μW to 300 mW.
62. The method of claim 59, wherein the step of selectively illuminating comprises illuminating a segment defined by a point spread function.
63. The method of claim 59, further comprising conjugating a linker to the primary target probe and detectably proximity-labeling a neighboring molecule in proximity to the target molecule via the activity of a detectable label.
64. The method of claim 63, wherein the step of detectably proximate to the label comprises a region of proximate to the label having a diameter of less than 5 μm, less than 2 μm, less than 1 μm, less than 500 nm, less than 300 nm, less than 200 nm, less than 100 nm, less than 50 nm, or less than 20 nm.
65. The method of claim 63, wherein the linker comprises a catalytic tag.
66. The method of claim 59, wherein the sample comprises at least 1, at least 100, at least 1000, or at least 10,000 living or fixed cells.
67. The method of claim 59, wherein the sample comprises fixed cells, fixed tissue, cell extracts, or tissue extracts.
68. The method according to claim 59, further comprising the step of subjecting the selectively illuminated sample to mass spectrometry or sequencing analysis.
69. The method of claim 59, wherein the activated photoactivatable moiety activates the primary target probe to have a free radical and form a covalent bond with an amino acid of the sample at the selected region of interest.
70. A mass spectrometry-implemented method for processing a sample to predict a biomarker, the method comprising: Dividing the samples into a light-labeled sample group and a non-labeled sample group; delivering the photoreactive probe and the primary target probe as claimed in any one of claims 22 to 49 to the photolabeled sample group and the non-labeled sample group; selectively illuminating selected areas of interest of the photo-labeled sample set and maintaining the unlabeled sample set in the dark, wherein the illuminating step allows the primary target probe to form a covalent bond with the sample; extracting a certain amount of probe-bound proteins from the photo-labeled sample group and the non-labeled sample group by affinity precipitation between the primary target probe and a certain amount of affinity magnetic beads; subjecting the extracted proteins to mass spectrometry analysis; calculating relative quantitative values of individual proteins in the identified protein list between the photo-labeled sample group and the non-labeled sample group based on the intensity values of the peptide fragments of the individual proteins; Determining a threshold value of the relative quantitative value between the optically labeled sample group and the non-labeled sample group; and After determining the threshold, at least one biomarker corresponding to the relative quantified value of the individual protein exceeding the threshold is predicted.
71. The method according to claim 70, further comprising the step of non-covalently conjugating the bait molecule to the target molecule in the sample.
72. A method according to claim 70, wherein the step of selectively illuminating the selected area of interest further comprises the step of activating the photoreactive portion in the selected area, thereby allowing the activated photoreactive portion to allow the primary target probe to form a covalent bond with the sample in the selected area of interest.
73. The method of claim 70, further comprising the step of delivering the decoy molecule of the photoreactive probe to the sample.
74. The method of claim 70, further comprising the step of removing unconjugated photoreactive probes from the sample, thereby allowing the photoreactive probes to direct the selective illumination at the selected region of interest.
75. The method according to claim 70, further comprising the steps of delivering the linker of the photoreactive kit according to any one of claims 43 and 45 to 47 to the sample and conjugating the linker to the primary target probe through affinity between the linker and the primary target probe.
76. The method of claim 75, wherein the linker is a fluorescent linker for identifying the location of the sample to which the primary target probe is covalently bound.
77. The method of claim 72, wherein the activated photoreactive moiety activates the primary target probe to have a free radical and form a covalent bond with an amino acid of the sample at the selected region of interest.
78. The method of claim 77, wherein the amino acid is selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine.
79. The method according to claim 75 or 76, further comprising the steps of delivering the tag-peroxidase of the photoreactive kit according to any one of claims 46 to 47 to the sample and conjugating the tag-peroxidase to the linker, thereby allowing the tag-peroxidase to catalyze the additional target probe to form a covalent bond between the additional target probe and the sample.
80. The method according to claim 79, wherein the tag-peroxidase activates the additional target probe to have a free radical at the target portion of the additional target probe and forms a covalent bond between the target portion of the additional target probe and tyrosine of the sample.
81. A mass spectrometry-implemented method for processing a photolabeled sample to identify a list of biomarkers, the method comprising: Obtain samples; delivering a photoreactive kit as claimed in any one of claims 22 to 49 to the sample; selectively illuminating a selected region of interest of the biological sample, thereby allowing the primary target probe to label proteins of the sample at the selected region of interest; extracting a certain amount of probe-labeled protein from the sample by affinity precipitation between the primary target probe and a certain amount of affinity magnetic beads; subjecting the extracted proteins to mass spectrometry analysis; and The extracted protein of the sample is identified.
82. The method according to claim 81, further comprising the step of calculating intensity values of peptide fragments of each protein of the list of identified proteins of the sample.
83. The method of claim 81, further comprising the step of sorting said list of identified proteins according to said intensity value of each protein.
84. The method according to claim 81, further comprising the step of non-covalently conjugating the bait molecule to the target molecule in the sample.
85. A method according to claim 81, wherein the step of selectively illuminating the selected area of interest further comprises the step of activating the photoreactive portion in the selected area, thereby allowing the activated photoreactive portion to allow the primary target probe to form a covalent bond with the sample at the selected area of interest.
86. The method of claim 81, further comprising the step of delivering the decoy molecule of the photoreactive probe to the sample.
87. The method of claim 81, further comprising the step of removing unconjugated photoreactive probes from the sample, thereby allowing the photoreactive probes to direct the selective illumination at the selected region of interest.
88. The method according to claim 81, further comprising the steps of delivering the linker of the photoreactive kit according to any one of claims 43 and 45 to 47 to the sample and conjugating the linker to the primary target probe through affinity between the linker and the primary target probe.
89. The method of claim 88, wherein the linker is a fluorescent linker for identifying the location of the sample to which the primary target probe is covalently bound.
90. The method of claim 85, wherein the activated photoreactive moiety activates the primary target probe to have a free radical and form a covalent bond with an amino acid of the sample at the selected region of interest.
91. The method of claim 90, wherein the amino acid is selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine.
92. The method according to claim 88 or 89, further comprising the steps of delivering the tag-peroxidase of the photoreactive kit according to any one of claims 46 to 47 to the sample and conjugating the tag-peroxidase to the linker, thereby allowing the tag-peroxidase to catalyze the additional target probe to form a covalent bond between the additional target probe and the sample.
93. The method according to claim 92, wherein the tag-peroxidase activates the additional target probe to have a free radical at the target portion of the additional target probe and forms a covalent bond between the target portion of the additional target probe and tyrosine of the sample.
Citation Information
Patent Citations
Microscope-based system and method for image-guided microscopic illumination
US20180367717A1
